Processes and intermediates for preparation of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1h-pyrazole-4-carboxamide

JP2024167307AActive Publication Date: 2024-12-03LOXO ONCOLOGY INC
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2024146059
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-09-10
Filing Date
2024-08-28
Publication Date
2024-12-03
Estimated Expiration
2041-09-09

Smart Images

  • Figure 2024167307000001
    Figure 2024167307000001
  • Figure 2024167307000002
    Figure 2024167307000002
  • Figure 2024167307000003
    Figure 2024167307000003
Patent Text Reader

Abstract

To provide processes and key intermediates for the preparation of (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide.SOLUTION: There is provided a process for preparing (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1H-pyrazole-4-carboxamide that uses N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro-2-methoxy-benzamide as an intermediate.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Background technology]

[0001] The present invention relates to the fields of pharmaceutical chemistry and synthetic organic chemistry, and is directed to the preparation of (S)-5-amino-3-(4- ((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1 Method for the synthesis of (1H-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide The present invention provides a process and key intermediates for the synthesis of 1,2-dichloro-1,2-trimethylsiloxyphenyl (1,2-dichloro-1,2-trimethylsiloxyphenyl)-2,3-dimethyl-1,4-propanediol ...4-dimethyl-1,5-tri

[0002] Bruton's tyrosine kinase (BTK) is a cytoplasmic tyrosine kinase related to src. BTK is a member of the IL-1 c family. It is involved in the development of normal white blood cells known as B cells. Plays a key role in the B cell antigen receptor signaling pathway required for activation and survival BTK also plays an important role in the proliferation and survival of a variety of B cell malignancies. Thus, BTK is a promising candidate for the treatment of chronic lymphocytic leukemia, Waldenström's hypergammaglobulinemia, and other cancers. A number of B-cell leukemias and leukemias, including erythrocytopenic leukemia, mantle cell lymphoma, and marginal zone lymphoma It is a useful molecular target for the treatment of cancer and lymphoma.

[0003] The compound, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamide 1-(1,1,1-trifluoropropan-2-yl)-1H -pyrazole-4-carboxamide has the following structure and is referred to herein as having formula (I): It may be referred to as a compound. [ka] Hereinafter, the compound of formula (I) will be referred to as (S)-5-amino-3-(4-((5-fluoro-2 -Methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane 5-amino-3-[4- [[(5-fluoro-2-methoxy-benzoyl)amino]methyl]phenyl]-1-[ (1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-4-carboxylate The compounds of formula (I) may also be referred to as amides. The compounds of formula (I) are disclosed in US Pat. No. 6,399,413 and US Pat. No. 6,399,413. Formulations of the compound of formula (I) are disclosed in WO2020 / 028258.

[0004] The above-mentioned documents WO2017 / 103611 and / or WO2020 / 028258 disclose the compound of formula The present disclosure describes a method for the synthesis of a compound of formula (I). This new process uses environmentally friendly reagents and provides optimal An efficient and cost-effective synthesis of compounds of formula (I) that allows for impurity control and forms highly pure crystalline material. The pure crystalline material allows for easy purification of the product. Furthermore, this embodiment can be used to prepare a compound of formula (I) To provide a novel intermediate. Summary of the Invention

[0005] The present embodiments provide methods and novel methods that can be used to prepare compounds of formula (I). This provides a useful intermediate.

[0006] One such embodiment is (S)-5-amino-3-(4-((5-fluoro-2 -Methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane A method for preparing (1H-phenyl-2-yl)-1H-pyrazole-4-carboxamide (I), comprising the steps of: viii) A compound of formula (III) [ka] , (In the formula, PG 1 are -CH3, -CH2CH3, -C(CH3)3, -CH2CH= CH2, methoxymethyl, tetrahydropyran, benzyl, trimethylsilyl, tert -butyldimethylsilyl, di-tert-butylisobutylsilyl, di-tert-butyl phenyl[pyren-1-ylmethoxy]silyl, tert-butyldiphenylsilyl, acetyl or benzoyl) and [(1S)-2,2,2-trifluoro-1-methyl- N-[[4-[5-amino-4-thiocyanyl]hydrazine (8) was coupled to give N-[[4-[5-amino-4-thiocyanyl]hydrazine (9). No-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-3 -yl]phenyl]methyl]-5-fluoro-2-methoxy-benzamide (10) or obtaining the salt; ix) N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-triphenylphosphine [Fluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro (S)-5-amino-3-(4-methoxy-benzamide (10) or its salt -((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1, 1-Trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide (I) and x) optionally, (S)-5-amino-3-(4-((5-fluoro-2-methoxyphenyl) 1-(1,1,1-trifluoropropane-2-yl)-2-phenyl-2-azamido (S)-5H-pyrazole-4-carboxamide (I) was crystallized to obtain the crystalline form of (S)-5H-pyrazole-4-carboxamide (I). -Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl )-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxylate providing a ruboxamide (I).

[0007] Another embodiment is an intermediate designated as a compound of formula (II), shown below: II) is N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl The compound is preferably 5-fluoro-2-methoxy-benzamide. [ka]

[0008] Thus, in another embodiment, the method comprises the steps of: In other words, the present disclosure relates to a method for producing a compound of formula (S)-5-a 3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)- 1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carbo In the preparation of oxamide (I), N-[[4-(2,2-dicyano-1-hydroxy-vinyl (phenyl)phenyl]methyl]-5-fluoro-2-methoxy-benzamide (II) This is a method.

[0009] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate is a compound of formula (III). [ka]

[0010] In formula (III), "PG 1 " refers to a protecting group. 1 Examples of what can constitute are -CH3, -CH2CH3, -C(CH3)3, -CH2CH=CH2, and methoxymethyl. ethyl, tetrahydropyranyl, benzyl, silyl, acetyl, or benzoyl, or and pharma- ceutically acceptable salts thereof. Silyl groups include trimethylsilyl, tert-butyl Dimethylsilyl, di-tert-butylisobutylsilyl, di-tert-butyl[pyrene but includes tert-butyldiphenylsilyl, tert-butyl-1-ylmethoxysilyl, and tert-butyldiphenylsilyl. Not limited to these.

[0011] A preferred embodiment of the present invention is a compound of formula (III) in which the compound is methyl PG 1 I have This compound is prepared as follows: N-[[4-(2,2-dicyano-1-methoxy-vinyl phenyl]methyl]-5-fluoro-2-methoxy-benzamide, This is expressed below as IA). [ka]

[0012] Thus, in one embodiment, the method of the invention comprises using a compound of formula (III) In other words, the present embodiment includes obtaining a compound of formula (I). 3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-( 1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide Some embodiments include the use of a compound of formula (III) in the preparation of compound (I). In one embodiment, this is achieved by reacting a compound of formula (IIIA) to obtain a compound of formula (I). and

[0013] Compounds of formula (II) can be prepared using the following Scheme I, which is described in more detail herein. It can be prepared using [ka]

[0014] Further embodiments include more efficient and environmentally friendly methods of producing compounds of formula (I). Such embodiments include those using a compound of formula (II) and / or a compound of formula (III) This may include:

[0015] Another embodiment is the reaction / reaction of Scheme II (described in more detail herein). Scheme II may include a method for preparing a compound of formula (I) comprising using a compound of formula (I) comprising: Using a compound of formula (II) to convert it to a compound of formula (III), and then The compound is converted to a compound of formula (I). [ka]

[0016] The embodiment depicted in Scheme II is represented using a compound of formula (III). Thus, the compounds of formula (IIIA) are a subgenus of the compounds of formula (III), in which PG 1 is methyl. A person skilled in the art can easily determine the PG of the compound of formula (III) 1 Using other species as It will be appreciated that similar schemes can be used and constructed. For example, different PG 1 are used) are all as disclosed herein. Similar techniques and schemes may be used to prepare compounds of formula (I). can.

[0017] As shown in Schemes I and II, the method includes one or more of the following steps: Viewable: i) 5-Fluoro-2-methoxy-benzoic acid (1) is converted to 5-fluoro-2-methoxy obtaining oxy-benzoyl chloride (2); ii) 5-Fluoro-2-methoxy-benzoyl chloride (2) with 4-(aminomethyl ) benzoic acid to give 4-[[(5-fluoro-2-methoxy-benzoyl ) obtaining amino]methyl]benzoic acid (3) or a salt thereof; iii) 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzo Fragrance acid (3) or its salt is reacted with 4-[[(5-fluoro-2-methoxy-benzoyl)amino] methyl]benzoyl chloride (4), iv) 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzo The aryl chloride (4) was reacted with malononitrile to give N-[[4-(2,2-dicyano- 1-Hydroxy-vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzaldehyde obtaining mide (II); v) N'-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]benzohydrin The azide (6) or its salt is reacted with [(1S)-2,2,2-trifluoro-1-methyl-ethyl hydrazine hydrochloride (7), vi) [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine hydrochloride The salt (7) was reacted with [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine ( 8) Step 2: Convert to vii) N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl

[0036] 5-fluoro-2-methoxy-benzamide (II) is reacted with a compound of formula (III) [ka] , (In the formula, PG 1 are -CH3, -CH2CH3, -C(CH3)3, -CH2CH= CH2, methoxymethyl, tetrahydropyran, benzyl, trimethylsilyl, tert -butyldimethylsilyl, di-tert-butylisobutylsilyl, di-tert-butyl phenyl[pyren-1-ylmethoxy]silyl, tert-butyldiphenylsilyl, acetyl or benzoyl; viii) a compound of formula (III) [ka] , [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine (8) or reacts with its salt to give N-[[4-[5-amino-4-cyano-1-[(1S)-2 ,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl obtaining 5-fluoro-2-methoxy-benzamide (10) or a salt thereof; ix) N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-triphenylphosphine [Fluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro 5-Amino-3-[4-[[( 5-Fluoro-2-methoxy-benzoyl)amino]methyl]phenyl]-1-[(1S )-2,2,2-Trifluoro-1-methyl-ethyl]pyrazole-4-carboxamide and x) optionally 5-amino-3-[4-[[(5-fluoro-2-methoxy-benzoyl) 1-[(1S)-2,2,2-trifluoro-1-(yl)amino]methyl]phenyl]- methyl-ethyl]pyrazole-4-carboxamide (I) was crystallized to obtain the crystalline form of 5- Amino-3-[4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl] Phenyl]-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazo to provide aryl-4-carboxamide (I).

[0018] In a further embodiment, there is provided an intermediate compound selected from: [ka] (In the formula, PG 2 is fluorenylmethoxycarbonyl, tert-butoxycarbonyl, Benzylcarbonyl, trifluoroacetamide, phthalimide, benzyl, triphenyl dimethyl, benzylideneamine, p-toluenesulfonamide, PG 1 is -CH 3, -CH2CH3, -C(CH3)3, -CH2CH=CH2, methoxymethyl, tetramethyl Hydropyranyl, benzyl, trimethylsilyl, tert-butyldimethylsilyl, dihydropyranyl, -tert-Butylisobutylsilyl, di-tert-butyl[pyren-1-ylmethoxy] silyl, tert-butyldiphenylsilyl, acetyl, or benzoyl). Some of the methods and processes by which the above compounds can be converted into compounds of formula (I) Embodiments are described and illustrated herein.

[0019] Detailed Description of the Invention Here, the compound N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl The present invention describes the compound [Nyl]methyl-5-fluoro-2-methoxy-benzamide. [ka]

[0020] This compound of formula (II) can be made according to the methods outlined herein. The compound of formula (II) can be reacted to produce a compound of formula (I). Specifically, after the compound of formula (II) is obtained, the compound of formula (II) is reacted, for example, with the following sequence: can be converted to a compound of formula (I) using one or more of the following steps: The compound of formula (II) is reacted to give N-[[4-(2,2-dicyano-1-methoxy- Vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzamide (IIIA) obtaining a N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl]-5- Fluoro-2-methoxy-benzamide (IIIA) and [(1S)-2,2,2-trifluorophenyl Fluoro-1-methyl-ethyl hydrazine (8) or a salt thereof to form a fluoro-1-methyl-ethyl hydrazine (9) -[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro-1 -methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro-2-methyl obtaining thoxy-benzamide (10) or a salt thereof; N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro -1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro-2 -Methoxy-benzamide (10) or its salt to give (S)-5-amino-3-(4-(( 5-Fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trimethylphenyl) Synthesis of trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide (I) a step of: Optionally, 5-amino-3-[4-[[(5-fluoro-2-methoxy-benzoyl )amino]methyl]phenyl]-1-[(1S)-2,2,2-trifluoro-1-methyl [1-ethyl]pyrazole-4-carboxamide (I) was crystallized to give the crystalline form (S)- 5-Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl 1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-yl Providing a carboxamide (I).

[0021] The step of reacting the compound of formula (II) may include reacting the compound of formula (II) with the compound of formula (III) In some embodiments, this involves converting a compound of formula (II) This reaction can be carried out by reacting the compound with a protecting group. Other methods of performing the above steps (which may be performed using the same method) may also be used.

[0022] The above N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl] -5-fluoro-2-methoxy-benzamide (IIIA) and [(1S)-2,2,2- trifluoro-1-methyl-ethyl]hydrazine (8) can be carried out under basic conditions, but other conditions such as direct conversion from the hydrazine salt can also be used. It is possible.

[0023] Finally, as mentioned above, a compound of formula (I) is obtained from the above synthetic steps. A selective crystallization step can be used to purify this compound. However, other methods and / or reactions and / or conditions can be used to convert a compound of formula (II) to a compound of formula (I ) can also be converted to the compound. Other purification methods besides crystallization can also be used. .

[0024] Compounds of formula (III) which can be converted to compounds of formula (I) by reaction are also described herein. In one embodiment, the compound of formula (III) is a compound of formula (IIIA) and P.G. 1 is methyl, and N-[[4-(2,2-dicyano-1-methoxy-vinyl [1-phenyl]phenyl]methyl]-5-fluoro-2-methoxy-benzamide. [ka]

[0025] The compound of formula (IIIA) can be converted to a compound of formula (I). In this case, the conversion is done as follows: N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl]-5- Fluoro-2-methoxy-benzamide (IIIA) and [(1S)-2,2,2-trifluorophenyl Fluoro-1-methyl-ethyl hydrazine (8) or a salt thereof to form a fluoro-1-methyl-ethyl hydrazine (9) -[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro-1 -methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro-2-methyl to obtain thoxy-benzamide (10) or a salt thereof; N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro -1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro-2 -Methoxy-benzamide (10) or its salt to give (S)-5-amino-3-(4-(( 5-Fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trimethylphenyl) Synthesis of trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide (I) do, Optionally, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamide Amido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)- 1H-pyrazole-4-carboxamide (I) was crystallized to obtain the crystalline form of (S)-5- 3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)- 1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carbo The present invention provides the oxamide (I).

[0026] As mentioned above, this N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl 1S)-methyl-5-fluoro-2-methoxy-benzamide (IIIA) and Coupling with 2,2,2-trifluoro-1-methyl-ethyl]hydrazine (8) The above steps can be carried out under basic conditions, although other conditions can also be used. The compound of formula (I) can also be obtained from the above synthesis steps. The compound can be purified using other methods and techniques. and / or reactions and / or conditions are used to convert a compound of formula (II) to a compound of formula (I). Other purification methods than crystallization can also be used.

[0027] The (S)-5-amino-3-(4-((5-fluoro-2-methoxy) Cibenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2- The method for preparing (1H-yl)-1H-pyrazole-4-carboxamide (I) comprises the following steps: For convenience, the compound numbers of Schemes I and II are included herein: i) 5-fluoro-2-methoxy-benzoic acid (1) or a salt thereof is converted to 5-fluoro obtaining 2-methoxy-benzoyl chloride (2); ii) 5-fluoro-2-methoxy-benzoyl chloride ( 2) is coupled with 4-(aminomethyl)benzoic acid to give 4-[[(5-fluoro- Obtaining 2-methoxy-benzoyl)amino]methyl]benzoic acid (3) or a salt thereof , iii) 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzo Fragrance acid (3) or its salt is reacted with 4-[[(5-fluoro-2-methoxy-benzoyl)amino] methyl]benzoyl chloride (4), iv) 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzo The aryl chloride (4) was reacted with malononitrile to give N-[[4-(2,2-dicyano- 1-Hydroxy-vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzaldehyde obtaining mide (II); v) N'-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]benzohydrin The azide (6) or a salt thereof is deprotected to give [(1S)-2,2,2-trifluoro-1-methyl obtaining 1-ethyl-1,3-dihydrohydrazine hydrochloride (7); vi) [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine hydrochloride The salt (7) was reacted with [(1S)-2,2,2-trifluoro-1-methyl-ethyl hydrazine (8), vii) N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl [5-fluoro-2-methoxy-benzamide (II) was converted with an alkylating agent to give , N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl]-5- Obtaining fluoro-2-methoxy-benzamide (IIIA), viii) N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl [(1S)-2,2, 2-trifluoro-1-methyl-ethyl]hydrazine (8) under basic conditions. N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro 1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro- Obtaining 2-methoxy-benzamide (10) or a salt thereof; ix) N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-triphenylphosphine [Fluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro (S)-5-amino-3-(4-methoxy-benzamide (10) or its salt -((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1, 1-Trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide (I) and x) optionally, (S)-5-amino-3-(4-((5-fluoro-2-methoxyphenyl) 1-(1,1,1-trifluoropropane-2-yl)-2-phenyl-2-azamido (S)-5H-pyrazole-4-carboxamide (I) was crystallized to obtain the crystalline form of (S)-5H-pyrazole-4-carboxamide (I). -Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl )-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxylate Providing ruboxamide (I).

[0028] The above step i) is a step of reacting 5-fluoro-2-methoxy-benzoic acid (1) or a salt thereof with 5- Fluoro-2-methoxy-benzoyl chloride (2) is then converted to some In embodiments, the reaction may be a chlorination (e.g., reaction with a chlorinating agent, etc.). Other conditions can be used to effect the conversion. Fluoro-2-methoxy-benzoic acid (1) or its salts are converted to 5-fluoro-2-methoxy- Conversion to the benzoyl chloride (2) can be achieved under a variety of chlorination conditions. For example, , thionyl chloride, oxalyl chloride, phosphorus(V) chloride, phosphorus(III) chloride, or other similar The above reagents can be used. Those skilled in the art can convert carboxylic acids to anhydrides or activated ester groups. It will be appreciated that other reagents and / or conditions, such as conversion, can be used.

[0029] The above step ii) is a reaction of 5-fluoro-2-methoxy-benzoyl chloride (2) with 4 -(aminomethyl)benzoic acid in combination with 4-[[(5-fluoro-2-methoxy- The method includes obtaining benzoyl)amino]methyl]benzoic acid (3) or its salt. In embodiments, the reaction may be an amide coupling reaction. Other conditions can also be used for the 5-fluoro-2- Methoxy-benzoyl chloride (2) in combination with 4-(aminomethyl)benzoic acid 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzoic acid (3) Obtaining the aryl group or its salt can be accomplished using a variety of non-nucleophilic bases. Diethylamine, diisopropylethylamine, or other similar reagents can be used. One of skill in the art will appreciate that other reagents and / or conditions may be used.

[0030] The above step iii) is a reaction of 4-[[(5-fluoro-2-methoxy-benzoyl)amine 5-fluoro-2-methoxy-benzoic acid (3) or its salts The process involves converting the benzoyl group to the corresponding benzoyl chloride (4). In embodiments, the reaction may be a chlorination and may be carried out using a chlorinating agent. Other conditions for carrying out the conversion may also be used. [(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzoic acid (3) or The salt of (5-fluoro-2-methoxy-benzoyl)amine is converted to 4-[[(5-fluoro-2-methoxy-benzoyl)amine using a chlorinating agent. Conversion of the benzoyl chloride (4) to 2-(methyl)benzoyl chloride (5) was achieved under a variety of chlorination conditions. For example, thionyl chloride, oxalyl chloride, phosphorus(V) chloride, phosphorus(III) chloride or other similar reagents can be used. Those skilled in the art can convert carboxylic acids to anhydrides or activated It will be appreciated that other reagents and / or conditions can be used, such as converting the aryl ester group to a carboxylic acid group. cormorant.

[0031] Step iv) above is 4-[[(5-fluoro-2-methoxy-benzoyl)amino ]methyl]benzoyl chloride (4) can be combined with malononitrile to give N-[[4-( 2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl]-5-fluoro-2- In some embodiments, the reaction comprises obtaining a methoxy-benzamide (II). The reaction may be an amide coupling reaction and may be accomplished using a non-nucleophilic base. Other conditions may be used to perform the process. (5-Fluoro-2-methoxy-benzoyl)amino]methyl]benzoyl chloride (4 ) in combination with malononitrile to give N-[[4-(2,2-dicyano-1-hydroxy -vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzamide (II) Obtaining the aryl group can be accomplished using a variety of non-nucleophilic bases, such as triethylamine, Diisopropylethylamine, or other similar reagents, can be used. It will be appreciated that other reagents and / or conditions may be used.

[0032] The above step v) is N'-[(1S)-2,2,2-trifluoro-1-methyl- [(1S)-2,2,2-triphenyl]benzohydrazide (6) or its salt to give [(1S)-2,2,2-triphenyl]benzohydrazide (7) or its salt. Several experimental methods have been used to obtain fluoro-1-methyl-ethyl hydrazine hydrochloride (7). In embodiments, the reaction can be a debenzoylation reaction, which can be carried out under acidic or basic conditions. You can use other types of conditions to perform this transformation. In some embodiments, N'-[(1S)-2,2,2-trifluoro -1-methyl-ethyl]benzohydrazide (6) or its salts, The conversion of the compound to trifluoro-1-methyl-ethyl hydrazine hydrochloride (7) can be carried out using acidic or This can be achieved under basic conditions. For example, acidic conditions can be used such as HCl or other similar. Alternatively, if basic conditions are used, KOH, K2CO3 Reagents such as ethanol, ethanolamine, ethanolamine derivatives, or other similar reagents may be added. Those skilled in the art will appreciate that other reagents and / or conditions may be used. You will understand that you can use it.

[0033] The above step vi) is [(1S)-2,2,2-trifluoro-1-methyl-ethyl ]hydrazine hydrochloride (7) to [(1S)-2,2,2-trifluoro-1-methyl- In some embodiments, the reaction includes converting the aryl hydrazine (8) to This can be done under basic conditions. Other conditions can also be used to effect this transformation. In some embodiments, [(1S)-2,2,2-trifluoro-1-methyl -ethyl]hydrazine hydrochloride (7) was reacted with [(1S)-2,2,2-trifluoro-1-methyl Conversion to [ethyl-1-yl]hydrazine (8) can be accomplished under a variety of basic conditions. For example, triethylamine, diisopropylethylamine, aqueous NaOH solution, aqueous LiOH solution A solution of K2CO3 in water, or other similar reagents can be used. It will be understood that any reagent and / or condition may be used.

[0034] Step vii) above is N-[[4-(2,2-dicyano-1-hydroxy-vinyl )phenyl]methyl]-5-fluoro-2-methoxy-benzamide (II) , N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl]-5- Some implementations include obtaining fluoro-2-methoxy-benzamide (IIIA). In some embodiments, this reaction may be an alkylation. Other conditions may be used to effect this transformation. In some embodiments, N-[[4-(2,2-dicyano-1 -Hydroxy-vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzamide From N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl] Thiyl-5-fluoro-2-methoxy-benzamide (IIIA) is useful in various alkylation reactions. This can be achieved under certain conditions, for example, trimethyl orthoformate, methyl triflate, tetrafluoroborate, etc. Trimethylammonium fluoroborate, N,N'-diisopropyl-O-methylisourea or other similar reagents may be used. Those skilled in the art will appreciate that other reagents and / or conditions may be used. You will understand that you can use it.

[0035] Step viii) above is N-[[4-(2,2-dicyano-1-methoxy-vinyl )phenyl]methyl]-5-fluoro-2-methoxy-benzamide (IIIA) and [( 1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine (8) or its salt and N-[[4-[5-amino-4-cyano-1-[(1S)-2 ,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl The reaction involves obtaining 5-fluoro-2-methoxy-benzamide (10). In some embodiments, the reaction may be a cyclization. Other conditions may be used to effect this transformation. In some embodiments, N-[[4-(2,2-dicyano-1 -Methoxy-vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzamide (IIIA) and [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine N-[[4-[5-amino-4-cyano- 1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-3-yl phenyl]phenyl]methyl]-5-fluoro-2-methoxy-benzamide (10) or its Obtaining salts can be accomplished using a variety of non-nucleophilic bases. For example, triethylamine. amine, diisopropylethylamine, or other similar reagents can be used. One will understand that other reagents and / or conditions can be used.

[0036] The above step ix) is N-[[4-[5-amino-4-cyano-1-[(1S)-2 ,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl (S)-5-fluoro-2-methoxy-benzamide (10) or a salt thereof Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl) -1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide In some embodiments, the reaction comprises synthesizing the voxamide (I). It can be a decomposition. Other conditions can also be used to perform this transformation. In an embodiment, N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2 -Trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5 -fluoro-2-methoxy-benzamide (10) or a salt thereof to obtain (S)-5-amino- 3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-( 1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide Synthesis of methyl ether (I) can be achieved under acidic conditions using a variety of acids. Use ethanesulfonic acid, trifluoroacetic acid, hydrochloric acid, polyphosphoric acid, sulfuric acid, or other similar reagents. Hydrolysis can be carried out under basic, oxidative, or metal-catalyzed / stoichiometric conditions. For example, potassium tert-butoxide, sodium hydroxide, , ruthenium hydroxide, manganese dioxide, copper(II) acetate, Perkin's catalyst, MnO2 / S iO2, or other similar reagents can be used. Those skilled in the art will appreciate that enzymatic reactions or amidine It will be understood that other reagents and / or conditions may be used, such as the use of intermediates.

[0037] The process for preparation described herein may be further described, wherein the chlorinating agent in step i) is thiodichloride. and in step ii) the non-nucleophilic base is triethylamine, and in step iii) The chlorinating agent in step (iv) is thionyl chloride, and the non-nucleophilic base in step (iv) is triethylamine. and the acid in step v) is hydrochloric acid, the temperature at which the reaction is carried out is 102° C., and The base in step vi) is triethylamine and the alkylating reagent in step vii) is ortho The reaction temperature is 92° C., and the oxidizing conditions of step ix) are The condition is methanesulfonic acid in water, the temperature at which the reaction is carried out is 85° C., and step x) The solvent in step i) is methanol. The method is preferably the method wherein the non-nucleophilic base in step ii) is triethylamine. A preferred process is that in step iii) the chlorinating agent is thionyl chloride. The preferred process is one in which the non-nucleophilic base in step iv) is triethylamine. A preferred process is that in step v) the acid is hydrochloric acid and the temperature at which the reaction is carried out is 102° C. A preferred process is where the base in step vi) is triethylamine. ) the alkylating agent is trimethyl orthoformate and the temperature at which the reaction is carried out is 92°C The method of the present invention is preferably such that the oxidizing conditions in step ix) are an aqueous methanesulfonic acid solution, A preferred process is one in which the reaction is carried out at 85° C. The solvent in step x) is methanol. The preferred production method is

[0038] In further embodiments, there is provided a compound selected from: [ka] (In the formula, PG 2 Fluorenyl methoxycarbonyl, tert-butoxycarbonyl , benzylcarbonyl, trifluoroacetamide, phthalimide, benzyl, triphenyl nylmethyl, benzylideneamine, p-toluenesulfonamide, PG 1 -C H3, -CH2CH3, -C(CH3)3, -CH2CH=CH2, methoxymethyl, tetramethyl tetrahydropyranyl, benzyl, trimethylsilyl, tert-butyldimethylsilyl, Di-tert-butylisobutylsilyl, di-tert-butyl[pyren-1-ylmeth silyl, tert-butyldiphenylsilyl, acetyl, or benzoyl) .

[0039] The following schemes (Schemes III-VI) may be used in the synthesis of compounds of formula (I): The following routes have not been formally completed, but they are intended to lead to the following compounds: It is believed that it can be produced in this manner.

[0040] [ka] The hydrazide (11) or its salt is reacted with a trifluoroacetate in a polar aprotic solvent such as THF. Condensation with propan-2-one can give the hydrazone (12) or its salt. The reduction of the hydrazone (12) or its salt can be carried out with NaBH4 or with palladium or This can be carried out by platinum-catalyzed hydrogenation to give the hydrazide (13) or its salt. The phenylacetate group can be removed by heating under acidic conditions such as HCl in MeOH. to give hydrazine (8), which may optionally be isolated as the HCl salt. Hydrazine (8) or its salts can be heated in a pressure vessel to produce potassium hydroxide. Reaction of tetramethylammonium (dicyanoethenylidene)azanide with tetramethylammonium (dicyanoethenylidene)azanide gives aminopyrazole (IV) or Those skilled in the art will appreciate that cyclization can be carried out directly from hydrazine or its salt. Conversion of the primary amine at C-3 of pyrazole to a bromide can be carried out in a variety of This can be achieved by using a brominating agent, among which CuBr2 can be used. The nitrile moiety of pyrazole (V) or its salt is converted to carboxamide (VI) or its salt. The conversion can be carried out using a suitable hydride-platinum complex such as the Ghaffar-Parkins catalyst. or in polar solvents such as H2O2, NaOH, and DMSO or EtOH. This can be achieved under basic conditions using a solvent to give the precursor of the boronic ester (14). The acid chloride (2) was converted to 1,2-dichlorophenyl ether (1) under Schotten-Baumann conditions using TEA in DCM. or directly from benzoic acid (1) or its salt using a suitable activating agent to produce the amide Coupling can be performed. Those skilled in the art will recognize that activating agents include HATU, PyBOP, C Understand that these include, but are not limited to, DI, DCC, EDCI and T3P The bromide moiety of amide (VII) can be converted to palladium, rhodium, or using a suitable catalyst such as zinc, and heating in a polar aprotic solvent such as DMSO to give the borohydride For example, Pd(PPh3)4 or Pd2 can be used to convert the phosphate ester (14). A palladium(0) source such as (dba)3 is used, and a base such as potassium carbonate or cesium carbonate is used. Suzuki coupling of boronic acid ester (14) with bromide (VI) or its salt using Compounds of formula (I) can be obtained using the above reaction.

[0041] [ka] Benzoic acid (15) or its salt can be converted to the corresponding acid salt using the typical chlorination conditions described above. The TH compound (16) can be converted to TH by the use of thionyl chloride. The reaction of chloride (16) with malononitrile using NaH in a suitable solvent such as F After acidic workup, the enol alcohol (17) can be obtained. The alkylation of the enol alcohol (17) can be carried out with a mild base such as NaHCO3, as previously described. with a suitable alkylating agent including trimethyl orthoformate or, alternatively, dimethyl sulfate. It will be appreciated that ring formation to a substituted pyrazole (19) or a salt thereof can be carried out by A solution of the above hydrazine (8) or its salt is added to an aryl enol ether (18). Those skilled in the art will appreciate that the primary amine (VIII) can be reacted with the primary amine (VIII) by acidic hydrolysis. It has been found that the acetal (19) or its salt can be synthesized via reductive amination after hydrolysis. Using the hydrolysis conditions described above, the nitrile of the substituted pyrazole (VIII) can be obtained. The aryl group can be converted to give carboxamide (IX) or a salt thereof. and benzoic acid (1) or a salt thereof to obtain a compound of the formula (I ) can be obtained.

[0042] [ka] As previously mentioned, the amide (VII) can be reacted with an amine base such as TEA or DIEA. from the acid chloride (2), or from a suitable reaction product as described in the description of Scheme III. It can be obtained directly from benzoic acid (1) or its salt using a derivatizing agent. Using an amine base such as A and heating in a protic solvent such as EtOH, malononitrile and hydrazine (8) or a salt thereof by cyclization to obtain pyrazole (X) or a salt thereof. Conversion of the boronic acid (XI) or a salt thereof, or alternatively an ester thereof, After introducing a suitable protecting group to the primary amine moiety such as a BOC group, the BISP A bisboronate source such as IN, an iridium catalyst, and a pyridine base are combined and heated to reflux. This can be accomplished by driving the reaction to completion using the Suzuki reaction previously described in Scheme III. Using aryl coupling between bromides (VII) and boronic acids (XI) under Compounds of formula (I) can also be obtained by the reaction of

[0043] [ka] The ester (21) or its salt can be prepared by maintaining low temperatures for both the reaction and subsequent work-up. HCl gas dissolved in MeOH was used to convert carboxylic acid (20) or its salt to The chlorine compounds according to Scheme I can be obtained using thionyl chloride or oxalyl chloride. Alternatively, T can be reacted with 22 under the same conditions as in Scheme IV. The chloride (22) can be dissolved in a mixture of malononitrile and NaH in a suitable solvent such as HF. The addition can be used to afford the enol alcohol (23) after acidic workup. Alkylation of the alcohol (23) was carried out using dimethyl sulfate in refluxing THF to give the enol (24). The hydrazine (8) or its salt and THF or the like can be used to obtain the diphenyl ether (XVII). by cyclization using an amine base such as TEA at reflux in a polar aprotic solvent of The pyrazole (XVIII) or its salt can be obtained by adding LiOH in aqueous MeOH. by selective hydrolysis of the ester (XVIII) or a salt thereof using mild conditions of Carboxylic acid (XX) or its salt can be obtained. Carbamate (XXI) or its salt The reaction is carried out by mixing DPPA, the appropriate alcohol (benzyl alcohol in this case), and TEA. The carbametazoline can be obtained by refluxing in toluene using carbamate rearrangement conditions. Cleavage of the aryl moiety was achieved by using TMS-I in acetonitrile to give the primary aryl group. A combination of polar solvents such as DMSO and EtOH can be used to give amine (VIII). The synthesis of substituted pyrazoles (VIII) under basic conditions using NaOH and H2O2 Hydrolysis of the nitrile moiety of (IX) can give the carboxamide (IX) or a salt thereof. The amide coupling of amine (IX) or its salt with benzoic acid (1) or its salt can be carried out. can be used to obtain the compounds of formula (I).

[0044] The (S)-5-amino-3-(4-((5-fluoro-2-methoxy) Cibenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2- The method for preparing (1H-yl)-1H-pyrazole-4-carboxamide (I) comprises the following steps: For convenience, the compound numbers of Scheme III are included herein: i) converting 2-phenylacetohydrazide (11) or a salt thereof to give 2-phenyl-N -[(Z)-(2,2,2-trifluoro-1-methyl-ethylidene)amino]acetate obtaining mide (12) or a salt thereof; ii) 2-phenyl-N-[(Z)-(2,2,2-trifluoro-1-methyl-ethyl 2-Phenyl-N'-[(1S)-(phenylene)amino]acetamide (12) or its salt Synthesis of 1,2,2-trifluoro-1-methyl-ethyl]acetohydrazide (13) Step iii) 2-phenyl-N'-[(1S)-2,2,2-trifluoro-1-methyl- Ethyl]acetohydrazide (13) or its salt is reacted with [(1S)-2,2,2-trifluoro -1-methyl-ethyl]hydrazine (8), iv) [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine (8 ) or a salt thereof with dicyanoethenylidene azanide or a pharma- ceutically acceptable salt thereof 3,5-diamino-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl obtaining the pyrazole-4-carbonitrile (IV) or a salt thereof; v) 3,5-diamino-1-[(1S)-2,2,2-trifluoro-1-methyl- ethyl]pyrazole-4-carbonitrile (IV) or its salt with 5-amino-3-bromo- 1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-4-carboxylate converting the carboxynitrile (V) or a salt thereof into vi) 5-amino-3-bromo-1-[(1S)-2,2,2-trifluoro-1-methyl 5-amino-3-ethyl-pyrazole-4-carboxamide (VI) or its salt -Bromo-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazo synthesizing benzoyl-4-carbonitrile (V) or a salt thereof; vii) converting 5-fluoro-2-methoxy-benzoic acid (1) or a salt thereof to give 5-fluoro-2-methoxy-benzoic acid (1) or a salt thereof; obtaining fluoro-2-methoxy-benzoyl chloride (2); viii) 5-fluoro-2-methoxy-benzoyl chloride using a non-nucleophilic base Coupling of 2 with 4-bromo-benzylamine affords N-[(4-bromophenyl)amine]. (nyl)methyl)-5-fluoro-2-methoxy-benzamide (VII) , ix) N-[(4-bromophenyl)methyl]-5-fluoro-2-methoxy-benz Amide (VII) to 5-fluoro-2-methoxy-N-[[4-(4,4,5,5-tetrafluoroethylene] tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]benzamide synthesizing the compound (14); and x) 5-fluoro-2-methoxy-N-[[4-(4,4,5,5-tetramethyl-1 ,3,2-Dioxaborolan-2-yl)phenyl]methyl]benzamide (14) -Amino-3-bromo-1-[(1S)-2,2,2-trifluoro-1-methyl- 1, by coupling with pyrazole-4-carboxamide (VI) or a salt thereof (S) -5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl Nyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4 - Obtaining carboxamide (I).

[0045] The (S)-5-amino-3-(4-((5-fluoro-2-methoxy) Cibenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2- The method for preparing (1H-yl)-1H-pyrazole-4-carboxamide (I) comprises the following steps: For convenience, the compound numbers of Scheme IV are included herein: i) 4-Formylbenzoic acid (15) or its salt is converted to 4-formylbenzoic acid chloride. obtaining a code (16); ii) 4-Formylbenzoyl chloride (16) was reacted with malononitrile under basic conditions. Pulling to obtain 2-[(4-formylphenyl)-hydroxy-methylene]propanediol obtaining a nitrile (17); iii) 2-[(4-formylphenyl)-hydroxy-methylene]propanedinitri From 2-[[4-(dimethoxymethyl)phenyl]-methoxy-methylene]propane (17) synthesizing propanedinitrile (18); iv) 2-[[4-(dimethoxymethyl)phenyl]-methoxy-methylene]propane Dinitrile (18) and [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hi 5-amino-3-[4-(dimethoxymethyl)-4-(phenylpropanediol) (8) or its salt to give )phenyl]-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyra obtaining zole-4-carbonitrile (19) or a salt thereof; v) 5-amino-3-[4-(dimethoxymethyl)phenyl]-1-[(1S)-2, 2,2-Trifluoro-1-methyl-ethyl]pyrazole-4-carbonitrile (19) or its salt, 5-amino-3-[4-(aminomethyl)phenyl]-1-[(1S)-2 ,2,2-trifluoro-1-methyl-ethyl]pyrazole-4-carbonitrile (VI II) or a salt thereof; vi) 5-amino-3-[4-(aminomethyl)phenyl]-1-[(1S)-2,2 ,2-trifluoro-1-methyl-ethyl]pyrazole-4-carbonitrile (VIII ) or a salt thereof to obtain 5-amino-3-[4-(aminomethyl)phenyl]-1-[(1S) -2,2,2-trifluoro-1-methyl-ethyl]pyrazole-4-carboxamide ( IX), and vii) 5-fluoro-2-methoxy-benzoic acid (1) or its salt with 5-amino-3- [4-(aminomethyl)phenyl]-1-[(1S)-2,2,2-trifluoro-1- methyl-ethyl]pyrazole-4-carboxamide (IX) or a salt thereof, S)-5-Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl) Phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole -4-To obtain carboxamide (I).

[0046] The (S)-5-amino-3-(4-((5-fluoro-2-methoxy) Cibenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2- The method for preparing (1H-yl)-1H-pyrazole-4-carboxamide (I) comprises the following steps: For convenience, the compound numbers of Scheme V are included herein: i) 5-fluoro-2-methoxy-benzoic acid (1) or a salt thereof is converted to 5-fluoro obtaining 2-methoxy-benzoyl chloride (2); ii) 5-fluoro-2-methoxy-benzoyl chloride ( 2) was coupled with 4-bromo-benzylamine to give N-[(4-bromophenyl ) methyl]-5-fluoro-2-methoxy-benzamide (VII), iii) [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine ( 8) or a salt thereof is reacted with malononitrile to obtain 5-amino-1-[(1S)-2,2, 2-trifluoro-1-methyl-ethyl]pyrazole-4-carbonitrile (X) or obtaining a salt of iv) 5-amino-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl ]pyrazole-4-carbonitrile (X) or a salt thereof is converted to [5-amino-4- Ano-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole- obtaining a 3-yl]boronic acid (XI) or a salt thereof; v) N-[(4-bromophenyl)methyl]-5-fluoro-2-methoxy-benzaldehyde amide (VII) with [5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro 1-methyl-1-ethyl]pyrazol-3-yl]boronic acid (XI) or its salt N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluorophenyl [0-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro obtaining 2-methoxy-benzamide (10) or a salt thereof; and vi) N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-triphenylphosphine [Fluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro 2-Methoxy-benzamide (10) or a salt thereof is converted to (S)-5-amino- 3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-( 1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide The step of obtaining (I).

[0047] The (S)-5-amino-3-(4-((5-fluoro-2-methoxy) Cibenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2- The method for preparing (1H-yl)-1H-pyrazole-4-carboxamide (I) comprises the following steps: For convenience, the compound numbers of Scheme VI are included herein: i) 4-(2-Methoxy-2-oxo-ethyl)benzoic acid (21) is converted to methyl obtaining 2-(4-chlorocarbonylphenyl)acetate (22); ii) Methyl 2-(4-chlorocarbonylphenyl)acetate (22) to methyl 2 -[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]acetate (23) a step of synthesizing iii) Methyl 2-[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl] Alkylation of acetate (23) to give methyl 2-[4-(2,2-dicyano-1-meth obtaining (Xy-vinyl)phenyl]acetate (XVII); iv) Methyl 2-[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]acetate The thiol (XVII) was reacted with [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine. 2-[4-[5-amino-4-cyano- 1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-3-yl obtaining phenyl]phenyl]acetate (XVIII) or a salt thereof; v) Methyl 2-[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trimethyl Fluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]acetate (XVI II) or a salt thereof, to obtain 2-[4-[5-amino-4-cyano-1-[(1S)- 2,2,2-Trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]acetic acid Obtaining an acid (XX) or a salt thereof, vi) 2-[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro oro-1-methyl-ethyl]pyrazol-3-yl]phenyl]acetic acid (XX) or its salt From benzyl N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2- Trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]carba synthesizing mate (XXI) or a salt thereof; vii) benzyl N-[[4-[5-amino-4-cyano-1-[(1S)-2,2, 2-Trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]ca 5-amino-3-[4-(aminomethyl)carbamate (XXI) or its salt is converted to 5-amino-3-[4-(aminomethyl)carbamate (XXI) or its salt. Phenyl]-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazo obtaining aryl-4 carbonitrile (VIII) or a salt thereof; viii) 5-amino-3-[4-(aminomethyl)phenyl]-1-[(1S)-2 ,2,2-trifluoro-1-methyl-ethyl]pyrazole-4-carbonitrile (VI II) or a salt thereof from 5-amino-3-[4-(aminomethyl)phenyl]-1-[(1 S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-4-carboxamide synthesizing the compound (IX) or a salt thereof; and ix) 5-Fluoro-2-methoxy-benzoic acid (1) with 5-amino-3-[4-(amino (1S)-2,2,2-trifluoro-1-methyl-phenyl )-5-arylpyrazole-4-carboxamide (IX) or a salt thereof to give (S)-5-arylpyrazole-4-carboxamide (IX) or a salt thereof 3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)- 1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carbo Obtaining oxamide (I).

[0048] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate is a compound of formula (IV). [ka]

[0049] Thus, in one embodiment, the method comprises using a compound of formula (IV) or a salt thereof In other words, what is described herein is a method for producing a compound of formula (I) comprising the steps of: )-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)fluor (phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole- In the preparation of 4-carboxamide (I), 3,5-diamino-1-[(1S)-2,2, 2-trifluoro-1-methyl-ethyl]pyrazole-4-carbonitrile (IV) or This is a method for using the salt.

[0050] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate can be a compound of formula (V): [ka]

[0051] Thus, in one embodiment, the method comprises using a compound of formula (V) or a salt thereof In other words, described herein is a method for producing a compound of formula (I) by reacting (S) -5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl Nyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4 In the preparation of -carboxamide (I), 5-amino-3-bromo-1-[(1S)-2, 2,2-Trifluoro-1-methyl-ethyl]pyrazole-4-carbonitrile (V) or is a method of using the salt.

[0052] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate can be a compound of formula (VI): [ka]

[0053] Thus, in one embodiment, the method comprises using a compound of formula (VI) or a salt thereof In other words, what is described herein is a method for producing a compound of formula (I) comprising the steps of: )-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)fluor (phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole- In the preparation of 4-carboxamide (I), 5-amino-3-bromo-1-[(1S)-2 ,2,2-trifluoro-1-methyl-ethyl]pyrazole-4-carboxamide (VI ) or a salt thereof.

[0054] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate is a compound of formula (VII). [ka]

[0055] Thus, in one embodiment, the method comprises the steps of: In other words, the present disclosure relates to a method for producing a compound of formula (S)-5-a 3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)- 1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carbo In the preparation of oxamide (I), N-[(4-bromophenyl)methyl]-5-fluoro- This method uses 2-methoxy-benzamide (VII).

[0056] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate is a compound of formula (VIII). [ka]

[0057] Thus, in one embodiment, the method comprises using a compound of formula (VIII) In other words, described herein is a method for obtaining a compound of formula I) comprising the steps of: Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl) -1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide In the preparation of voxamide (I), 5-amino-3-[4-(aminomethyl)phenyl]- 1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-4-carboxylate This method uses carbomer hydrochloride (VIII).

[0058] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate can be a compound of formula (IX): [ka]

[0059] Thus, in one embodiment, the method comprises using a compound of formula (IX) or a salt thereof In other words, described herein is a method for preparing a compound of formula (I) by reacting (S) -5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl Nyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4 In the preparation of -carboxamide (I), 5-amino-3-[4-(aminomethyl)phenyl -1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole- This method uses 4-carboxamide (IX) or a salt thereof.

[0060] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, the intermediate is a compound of formula (X): [ka]

[0061] Thus, in one embodiment, the method comprises using a compound of formula (X) or a salt thereof In other words, described herein is a method for obtaining a compound of formula (I) comprising the steps of: 5-Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl 1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-yl In the preparation of carboxamide (I), 5-amino-1-[(1S)-2,2,2-trifluoromethyl] [fluoro-1-methyl-ethyl]pyrazole-4-carbonitrile (X) or its salts This is how to do it.

[0062] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate can be a compound of formula (XI): [ka]

[0063] Thus, in one embodiment, the method comprises using a compound of formula (XI) or a salt thereof In other words, described herein is a method for preparing a compound of formula (I) by reacting (S) -5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl Nyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4 In the preparation of -carboxamide (I), [5-amino-4-cyano-1-[(1S)-2 ,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]boronic acid (XI ) or a salt thereof.

[0064] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate is a compound of formula (XII). [ka]

[0065] Thus, in one embodiment, the method comprises the steps of: In other words, the present disclosure relates to a method for producing a compound of formula (S)-5-a 3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)- 1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carbo In the preparation of N-tert-butoxycarbonyl-N -[4-cyano-2-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pi The method uses azol-3-yl carbamate (XII).

[0066] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate is a compound of formula (XIII). [ka]

[0067] Thus, in one embodiment, the method comprises using a compound of formula (XIII) to produce a compound of formula ( In other words, described herein is a method for obtaining a compound of formula I) comprising the steps of: Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl) -1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide In the preparation of boxamide (I), tert-butyl N-tert-butoxycarbonyl- N-[4-cyano-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborola (1S)-2,2,2-trifluoro-1-methyl-ethyl)pi The method uses azol-3-yl carbamate (XIII).

[0068] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate is a compound of formula (XIV). [ka]

[0069] Thus, in one embodiment, the method comprises the steps of: In other words, the present disclosure relates to a method for producing a compound of formula (S)-5-a 3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)- 1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carbo In the preparation of oxamide (I), N-[[4-(2,2-dicyano-1-hydroxy-vinyl The method uses phenyl]methyl]carbamate (XIV).

[0070] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate is a compound of formula (XV). [ka]

[0071] Thus, in one embodiment, the method comprises the steps of: In other words, described herein is a method for producing a compound of the formula (S)-5-aminopropyl ether. No-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1 -(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxylate In the preparation of tert-butyl N-[[4-(2,2-dicyano-1-methylphenyl)amide (I), The method uses methoxy-(vinyl)phenyl]methyl]carbamate (XV).

[0072] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate is a compound of formula (XVI): [ka]

[0073] Thus, in one embodiment, the method comprises using a compound of formula (XVI) or a salt thereof In other words, what is described herein is a method for preparing a compound of formula (I) comprising the steps of: )-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)fluor (phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole- In the preparation of 4-carboxamide (I), tert-butyl N-[[4-[5-amino- 4-Cyano-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazo Methods using aryl-3-ylphenylmethylcarbamate (XVI) or its salts It is.

[0074] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate is a compound of formula (XVII). [ka]

[0075] Thus, in one embodiment, the method comprises using a compound of formula (XVII) In other words, described herein is a method for obtaining a compound of formula I) comprising the steps of: Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl) -1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide In the preparation of boxamide (I), methyl 2-[4-(2,2-dicyano-1-methoxy- The method uses (XVII) (vinyl)phenyl] acetate.

[0076] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate can be a compound of formula (XVIII): [ka]

[0077] Thus, in one embodiment, the method comprises reacting a compound of formula (XVIII) or a salt thereof In other words, the present disclosure includes a process for obtaining a compound of formula (I) using (S)-5-Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl )phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazo In the preparation of methyl 2-[4-[5-amino-4-cyano]-4-carboxamide (I) No-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-3 3. A method of using 3-yl]phenyl]acetate (XVIII) or a salt thereof.

[0078] In another embodiment, different intermediates can be used to prepare the compounds of formula (I). Specifically, this intermediate can be represented by the formula (XIX): [ka]

[0079] Thus, in one embodiment, the method comprises using a compound of formula (XIX) or a salt thereof In other words, what is described herein is a method for preparing a compound of formula (I) comprising the steps of: )-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)fluor (phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole- In the preparation of 4-carboxamide (I), 2-[4-[5-amino-4-carbamoyl- 1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-3-yl The method uses phenyl]phenyl]acetic acid (XIX) or a salt thereof.

[0080] The reactions described herein can be carried out in conventional glass reaction systems using standard techniques known to those skilled in the art. This may be accomplished by using a gas instrument or by using an autoclave pressure chamber. These reactions may also be carried out in pipes in equipment designed for such transformations. These reactions may be carried out on a batch and / or production scale. Each may be carried out by either a batch process or a flow reaction method. The term "batch process" as used in the document refers to a process in which raw materials are combined in a reactor or vessel. The term "continuous" as used herein refers to a process in which the reaction is continued for 10 minutes at a time and the product is removed at the end of the reaction. "Continuous processing" or "flow reaction" is a process in which there is a continuous inflow of raw materials and an outflow of products. Such continuous processing refers to a completely continuous process starting from an initial starting material. It provides a platform from which the final product can be synthesized through a series of operations.

[0081] Individual isomers, enantiomers, and diastereomers can be separated using selective crystallization techniques or chiral At any convenient time in the synthesis of the compound of formula I, In this respect, it may be separated or divided by those skilled in the art (see, for example, J. Jacques, t al., “Enantiomers, Racemates, and Resolut ions”, John Wiley and Sons, Inc., 1981, and E. L. Eliel and SH Wilen, “Stereochemistry o f Organic Compounds”, Wiley-Interscience, (See, e.g., J. Med. 1994). Additionally, tautomers may occur in certain compounds of the present invention. For example, compound (II) may exist in any ratio of the following isomeric forms: [ka] These configurations are within the scope of the present embodiment.

[0082] In addition, certain intermediates described in the preparations below contain one or more nitrogen protecting groups. Variable protecting groups may be used in different occurrences depending on the particular reaction conditions and the particular transformation being performed. Protection and deprotection conditions are well known to those skilled in the art and can be found in the literature (e.g. "Greene's Protective Groups in Organic Synthesis”, Fourth Edition, by Peter GM Wuts and Theodora W. Greene,John Wiley an (See, e.g., U.S. Patent No. 6,333,623, 2007). The compounds, intermediates, and pharma- ceutically acceptable salts thereof are shown by name, formula number, compound It will be understood by those skilled in the art that the compounds may equally be referred to by number, or by number from the formula alone. For example, the formula (III) or (III):

[0083] A compound prepared by synthesis as described herein, or a pharma- ceutically acceptable derivative thereof. The salts may be prepared by a variety of procedures known in the art, some of which are Some are illustrated in the following schemes, preparations, and examples. If no chemical entity is specified, all individual enantiomers and mixtures thereof are included. Each particular synthetic step of the described route may be synthesized in different ways. The steps in the following schemes may be combined in a formula or from different schemes. The products of each step are extracted, evaporated, precipitated, chromatographed, filtered, triturated, and condensed. The product may be recovered by conventional methods well known in the art, including crystallization. The reactants are readily available to one skilled in the art. The reactions are generally carried out according to techniques known to those skilled in the art. Observe until completion using techniques such as TLC, HPLC, GC, LC / MS, RAMAN, etc. Those skilled in the art will appreciate that the techniques used will depend on the scale of the reaction, the size of the vessel in which the reaction is carried out, and the It will be appreciated that this will depend on a variety of factors, including the type and reaction itself.

[0084] As used herein, the term "reacting" refers to the use of any suitable chemical reaction. vinegar.

[0085] The abbreviations used herein are defined as follows: "DMSO" is dimethylsulfoxide; "EtOAc" refers to ethyl acetate. "EtOH" refers to ethanol or ethyl acetate. "GC" stands for gas chromatography. "HPLC" stands for high performance liquid chromatography. "LC / LCA" stands for "KF" and "KF" stands for "Karle Fischer Assay". "MS" refers to liquid chromatography-mass spectrometry. "MeOH" refers to methanol or "Methyl alcohol" stands for "MsOH" and "Methanesulfonic acid" stands for "MOM". methyl ether. "RAMAN" refers to Raman spectroscopy. "RPM" refers to revolutions per minute. "TLC" stands for thin layer chromatography. "Tec" stands for hepatocellular carcinoma. "THP" refers to tetrahydropyran. "DCM" refers to dihydropyran. "ACN" stands for acetonitrile. "Ghaffar-Parki The ns catalyst is a hydride (dimethylphosphinic acid - kP) [hydrogen bis(dimethylphosphinic acid)] [Nito-kP] refers to platinum(II), CAS number 173416-05-2. "DIEA" "DIA" stands for diisopropylethylamine. "TEA" stands for triethylamine. "DMA" stands for "P" stands for 4-dimethylaminopyridine. "TMS-I" stands for trimethylsilyl iodide. "DPPA" refers to diphenylphosphoryl azide. "FA" refers to formic acid. "B "OC" refers to the tert-butyloxycarbonyl group. "BOC2O" refers to Boc anhydride. tert-butoxycarbonyl tert-butyl carbonate. "rt" stands for "BISPIN" stands for (E)-1-pentene-1,2-diboronic acid bis(pyridinium) "T3P" refers to 2,4 ,6-Tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4, 6-trioxide. "PE" refers to petroleum ether or diethyl ether. "H ATU is N-[(dimethylamino)-1H-1,2,3-triazolo-[4,5-b ]pyridin-1-ylmethylene]-N-methylmethanaminium hexafluorophosphate "PyBOP" refers to benzylidene N-oxide, CAS number 148893-10-1; (1-isotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate "TFA" refers to trifluoroacetic acid, CAS number 128625-52-5 "CDI" refers to 1,1'-carbonyldiimidazole. "DMF" refers to dimethylformamide. "DCC" refers to N,N'-dicyclohexylcarbodiimide. "EDCI" refers to 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide. "dba" refers to the dibenzylideneacetone group. "Fmoc" refers to fluorenyl methacrylate. "Cbz" refers to the carboxybenzyl group. "Bn" refers to the benzoyl group. "Tr" refers to the trityl or triphenylmethyl group. "Ts" refers to the trityl or triphenylmethyl group. It refers to a silyl group or a toluenesulfonyl group.

[0086] The compound of formula (I), (S)-5-amino-3-(4-((5-fluoro-2-methoxyphenyl)- benzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl N-[[ 4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl]-5-fluoro- The compound of formula (II), N -[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl]-5-phenyl Fluoro-2-methoxy-benzamide can be prepared by the procedure shown in Scheme I. It is prepared using oro-2-methoxy-benzoic acid (1) or its salt.

[0087] [ka] The substituted benzoic acid (1) or its salt is dissolved in a suitable polar aprotic solvent, and thionyl chloride is added. , oxalyl chloride, or phosphorus pentachloride. The acyl chloride (2) is obtained as an intermediate. Then, 4-(aminomethyl)benzoic acid is reacted with the acyl chloride (3). Coupling with silyl (2) gives the further substituted benzoic acid (3) or its salt. The acyl chloride intermediate (4) can be synthesized under similar conditions to those for the acyl chloride (2). Malononitrile is dissolved in a suitable solvent and stirred until the mixture becomes homogeneous, and then chloride is added. The aryl acyl intermediate (4) is then added to a suitable solvent. To a cold solution of a non-nucleophilic base, aryl enol (II) or Add for a period of time sufficient to convert the mixture to its salt. After the formation of an insoluble solid, the aryl enol (II) or its salt is isolated by filtration. do.

[0088] [ka] A suitable reagent, such as trimethyl orthoformate, is typically used in the synthesis of the enol ether moiety. Aryl enols (II) can be converted to aryl enol ethers using equivalent reagents that can be used The substituted hydrazine salt (7) is prepared as described in WO17 / 103611 as follows: The reaction is prepared according to the reaction conditions previously disclosed. It is dissolved in a suitable polar protic solvent and cooled. To a solution of (7), a non-nucleophilic base is added to form monosubstituted hydrazine (8). The cyclization to the hydrazine (10) or a salt thereof can be carried out by reacting a solution of the above hydrazine (8) or a salt thereof with Similarly, aryl enol ethers dissolved in polar protic solvents and isolated by filtration (III) is then added to the nitrile of the pyrazole (10) or The salt is hydrolyzed under aqueous acidic conditions and heated to generate the primary amide (I), which can then be reacted with the appropriate The reaction mixture is pH adjusted with aqueous base and then isolated by filtration. It will be appreciated that this transformation may be carried out under basic conditions and / or in the presence of a metal catalyst. Crystallization and purification of I) was carried out according to the conditions previously disclosed in WO2020 / 028258. This is accomplished to give the compound of formula (I) as a white crystalline solid.

[0089] As stated above, the above structures and schemes are obtained using formula (IIIA). Thus, formula (IIIA) is a subspecies of the broader formula (III). and in formula (IIIA), PG 1 (PG is methyl). 1 As other species It will be appreciated that similar schemes and examples can be made using the same method. 1 and converting the compound into compound (10) or a salt thereof and / or finally compound (I). The transformations used to convert the .alpha.-to- ...

[0090] The following schemes detail synthetic routes that may be used in the synthesis of compounds of formula (I): Although the following route has not been formally completed, the following compound can be prepared as follows: It is believed that this is possible.

[0091] [ka] The hydrazide (11) or its salt is reacted with a trifluoroacetate in a polar aprotic solvent such as THF. Condensation with propan-2-one can give the hydrazone (12) or its salt. The reduction of the hydrazone (12) or its salt can be carried out with NaBH4 or with palladium or This can be carried out by platinum-catalyzed hydrogenation to give the hydrazide (13) or its salt. The phenylacetate group can be removed by heating under acidic conditions such as HCl in MeOH. to give hydrazine (8), which may optionally be isolated as the HCl salt. Hydrazine (8) or its salts can be heated in a pressure vessel to produce potassium hydroxide. Reaction of tetramethylammonium (dicyanoethenylidene)azanide with tetramethylammonium (dicyanoethenylidene)azanide gives aminopyrazole (IV) or The conversion of the primary amine at the C-3 position of the pyrazole to a bromide can be carried out in various ways. This can be achieved by using a variety of brominating agents, among which CuBr2 can be used. The nitrile moiety of pyrazole (V) or its salt is converted to carboxamide (VI) or its salt. The conversion of or under mild conditions such as H2O2, NaOH, and polar solvents such as DMSO or EtOH. This can be achieved under basic conditions using a solvent. To this end, the acid chloride (2) was prepared under Schotten-Baumann conditions using TEA in DCM. from benzoic acid (1) or its salts using a suitable activating agent. Those skilled in the art will recognize that activating agents include HATU, PyBOP, It is understood that these include, but are not limited to, CDI, DCC, EDCI and T3P. The bromide moiety of amide (VII) can be catalyzed by palladium, rhodium, or or zinc, and heating in a polar aprotic solvent such as DMSO to form the The carboxylic acid ester (14) can be converted to the corresponding carboxylic acid ester (15) by, for example, Pd(PPh3)4 or Pd A palladium(0) source such as 2(dba)3 is used, and a salt such as potassium carbonate or cesium carbonate is used. Suzuki coupling of boronic ester (14) with bromide (VI) or its salt using the Compounds of formula (I) can be obtained using the above reaction.

[0092] [ka] Benzoic acid (15) or its salt can be converted to the corresponding acid salt using the typical chlorination conditions described above. The TH compound (16) can be converted to TH by the use of thionyl chloride. The reaction of chloride (16) with malononitrile using NaH in a suitable solvent such as F After acidic workup, the enol alcohol (17) can be obtained. The alkylation of the enol alcohol (17) can be carried out with a mild base such as NaHCO3, as previously described. with a suitable alkylating agent including trimethyl orthoformate or, alternatively, dimethyl sulfate. It will be appreciated that ring formation to a substituted pyrazole (19) or a salt thereof can be carried out by A solution of the above hydrazine (8) or its salt is added to an aryl enol ether (18). Those skilled in the art will appreciate that the primary amine (VIII) can be reacted with the primary amine (VIII) by acidic hydrolysis. It has been found that the acetal (19) or its salt can be synthesized via reductive amination after hydrolysis. Using the hydrolysis conditions described above, the nitrile of the substituted pyrazole (VIII) can be obtained. The aryl group can be converted to give carboxamide (IX) or a salt thereof. and benzoic acid (1) or a salt thereof to obtain a compound of the formula (I ) can be obtained.

[0093] [ka] As previously mentioned, the amide (VII) can be reacted with an amine base such as TEA or DIEA. or from the acid chloride (2) by suitable activation as described in the description of Scheme 3. It can be obtained directly from benzoic acid (1) or its salt using an agent such as DIEA. and heating in a protic solvent such as EtOH. Cyclization of hydrazine (8) or its salt to obtain pyrazole (X) or its salt. The conversion of the boronic acid (XI) or a salt thereof, or alternatively an ester thereof, can be carried out by: After introducing a suitable protecting group to the primary amine moiety, such as a BOC group, BISPIN A bisboronate source such as bromine, an iridium catalyst, and a pyridine base are combined and heated to reflux to obtain The reaction can be carried to completion by using Suzuki conditions as previously described in Scheme III. Using aryl coupling between bromide (VII) and boronic acid (XI), Compounds of formula (I) can also be obtained.

[0094] [ka] The ester (21) or its salt can be prepared by maintaining low temperatures for both the reaction and subsequent work-up. HCl gas dissolved in MeOH was used to convert carboxylic acid (20) or its salt to The chlorine compounds according to Scheme I can be obtained using thionyl chloride or oxalyl chloride. Alternatively, T can be reacted with 22 under the same conditions as in Scheme IV. Addition of chloride (22) to a mixture of malononitrile and NaH in a suitable solvent such as HF Addition of the enolic acid can be used to give the enol alcohol (23) after acidic workup. Alkylation of the alcohol (23) was carried out using dimethyl sulfate in refluxing THF to give the enol The ether (XVII) can be obtained by reacting hydrazine (8) or a salt thereof with THF or the like. Cyclization using an amine base such as TEA at reflux in a polar aprotic solvent affords the LiOH in MeOH solution can be used to obtain tetrazole (XVIII) or its salt. Selective hydrolysis of the ester (XVIII) or its salt using mild conditions can be used to obtain the carboxylate (XVIII). Carbamate (XXI) or its salt can be obtained by the reaction of , DPPA, the appropriate alcohol (in this case benzyl alcohol), TEA Curtius The carbamates can be obtained by refluxing in toluene using rearrangement conditions. Cleavage of the moiety was achieved by using TMS-I in acetonitrile to give the primary amine. The compound (VIII) can be obtained by using a combination of polar solvents such as DMSO and EtOH. Substituted pyrazoles (VIII) under basic conditions, both using NaOH and H2O2 Hydrolysis of the nitrile moiety of the compound (IX) can give the carboxamide (IX) or a salt thereof. The amide coupling of amine (IX) or its salt with benzoic acid (1) or its salt is used to obtain the desired product. Thus, the compound of formula (I) can be obtained.

[0095] The following preparations and examples further illustrate this invention.

[0096] Preparation 1 [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine hydrochloride [ka] At room temperature, N'-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]benzene Zohydrazide (200g, 8.61mol), water (300g, 166.53mol), 3 5% concentrated HCl (360 g, 34.50 mol, 35 w%) and m-xylene (150 m L) are added together. The contents are stirred and heated to 102° C. for 24 hours. The reaction is then The mixture was cooled to 85° C., toluene (1200 mL) was added, and the solution was slowly cooled to 25° C. The layers are separated and the organic layer is discarded. The aqueous layer is washed with toluene (300 mL) and cooled to 25 °C. The layers were separated and the organic layer was discarded, and the title compound (709 g, 20w%) is obtained.

[0097] Preparation 2 N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl]-5- Fluoro-2-methoxy-benzamide [ka] 4-[[(5-fluoro-2-methoxyphenyl)-2-(2-methoxyphenyl)-1,2-difluorophenyl]-2,4-difluoropropanediol (ACN) (2000 mL) at 25 °C under N 1 containing 250 g (824 mmol) of 1-benzoyl)amino]methyl]benzoic acid Then, thionyl chloride (117.7 g, 989 mmol) was added dropwise, and the mixture was stirred at 25° C. for 2 hours. The solution is concentrated to a small volume, ACN (750 mL) is added, and the solution is concentrated to a small volume again. ACN (1000 mL) was added and the solution was stirred at 30° C. for 30 min, then ACN ( Add 250 mL of TE together with malononitrile (81.7 g, 1.24 mol). A solution of A (191.8 g, 1.90 mol) and ACN (250 mL) was added to empty container 2. Add 100 ml of water, cool to -5°C and stir for 120 minutes to reach a constant temperature. Maintain temperature at -5°C. While stirring, add the acid chloride / malononitrile solution in vessel 1 to the triethylamine solution in vessel 2. After the addition is complete, the reaction is stirred at -10°C for 15 hours. Aqueous HCl (1073 g, 1.285 HCl equivalents) was added and the temperature was adjusted to 10°C. This is then added to the product solution in vessel 2 while maintaining the temperature at 10° C. and stirred for 3 hours. The solids are filtered and the filter cake is washed with water. The solids are then separated into wet cake (66 The wet cake (9.2 g) was divided into two portions, and one portion (535.4 g) was used again in this experiment. The slurrying was continued, and the other wet cake portion (133.8 g) was dried and used for research purposes. The first wet cake (535.4 g) was set aside for reslurry. The mixture is transferred to a 40 mL vessel and ACN (700 mL) and water (1400 mL) are added. Heat to °C and stir for 15 hours. Reduce temperature to 10 °C and stir for 2 hours. Filter the solids. The solid was dried in vacuum at 60-65° to give the title compound (193.5 g, 55 1 mmol) is obtained. 1H NMR(400MHz,DMSO-d6)δ3.89(s, 3H),4.52(d,2H),7.18(m,1H),7.20(br,1H),7. 34(m,1H),7.36(d,2H),7.51(m,1H),7.57(d,2H ),8.85(m,1H).

[0098] Preparation 3 N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl]-5-phenyl Fluoro-2-methoxy-benzamide [ka] N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl]-5 -Fluoro-2-methoxy-benzamide (300 g, 849 mmol) was dissolved in orthoformic acid. Add dimethyl ether (3 L, 270.0 mol) to the mixture and heat to 92° C. for 18 h. The solution is cooled to 40°C and then heated under vacuum while maintaining the temperature below 50°C. The solution is concentrated to approximately 1200 g. The mixture is cooled to 20° C. to obtain the title compound (12 00g, 8.54mmol, 26% by weight solution).

[0099] Preparation 3a N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl]-5-phenyl Fluoro-2-methoxy-benzamide N-[[(4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl]- 5-Fluoro-2-methoxy-benzamide (20 g, 56.9 mmol) and orthogonal Trimethyl ester (190 g, 200 mL, 1790 mmol) was added and the mixture was cooled to 9 Heat to 5° C. for 15 h. Reduce temperature to 40° C. and add MeOH (200 mL). 200 ml of ethyl acetate was removed from the reaction mixture using reduced pressure (200 mbar) to maintain a temperature of 40° C. Repeat the process of adding MeOH (200 mL) and distilling six times. Achieve a final total solution volume of approximately 200 mL. Add N-[[4-(2,2-dicyano-1- Methoxy-vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzamide Seed, cool to 22° C., and stir the mixture overnight. If so, the crystals may be produced by a number of known techniques, as will be appreciated by those of skill in the art. The resulting solid is collected by filtration and washed with MeOH (100 mL). The title compound (13.3 g, 36.4 mmol, 64% yield) was obtained by drying in vacuum at 4° C. Obtained as a white solid. ES / MS m / z 388(M+Na), 366(M+H ), 1 H NMR 400MHz,(DMSO-d6)δ3.89(s,3H),3.9 0(s,3H),4.60(d,2H),7.19(dd,1H),7.35(m,1H ),7.52(dd,1H),7.55(d,2H),7.65(d,2H),8.93 (m,1H).

[0100] Preparation 4 N-[[4-[(1S)-5-amino-4-cyano-1-(2,2,2-trifluoro 1-Methyl-ethyl)pyrazol-3-yl]phenyl]methyl]-5-fluoro-2- Methoxy-benzamide [ka] N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]methyl at 15°C ]-5-Fluoro-2-methoxy-benzamide (1200 g, 8.5 mol, 26 wt. % solution), add 95% EtOH (1.14 L). Another solution containing (2-methylpropane-2-yl)hydrazine hydrochloride (total solution 709 g, 20 wt%) After adding 95% EtOH (600 mL) to the vessel, the temperature was maintained at 0-5°C. TEA (390 g, 38.5 mol) was added dropwise over 1 h. The solution was recorded as pH=9. While maintaining the temperature at 15-20°C, (1,1,1-trifluoropropane- 2-yl)hydrazine solution with N-[[4-(2,2-dicyano-1-methoxy-ethyl) phenyl]methyl]-5-fluoro-2-methoxybenzamide solution dropwise over 1 hour The container containing (1,1,1-trifluoropropan-2-yl)hydrazine is heated for 15 Rinse the reaction mixture into the reaction mass with 95% EtOH (510 mL) at 20 °C. Stir for 18 hours and add water (1200 mL) over 30 minutes at 25°C. 4-[(1S)-5-amino-4-cyano-1-(2,2,2-trifluoro-1-methyl (ethyl)pyrazol-3-yl)phenyl]methyl)-5-fluoro-2-methoxy -benzamide (1.5 g, 3.25 mmol) at 25° C. and stirred for 1 h. (3120 mL) is charged over 3 hours at 25° C. and stirring is continued for an additional 3 hours. The solid is filtered. and washed with 28% EtOH in water (2×1.4 L) and water (1.5 L). 95% EtOH (3.0 L) was added to the recovered wet cake and the mixture was heated to 65° C. Stir for 1 hour. Cool the reaction to 55°C and add water (3. Add 100 mL of water dropwise over 3 h. Cool the mixture to 21 °C and stir at 21 °C for 60 h. The solid was collected, washed with water (600 mL) and dried in vacuum at 55° C. for 24 h to give the title compound. Product (336g, yield 83%, purity 99.3%, analysis value 97.1%, chiral purity 99.7%) ) as an off-white solid. KF = 0.26 wt %, residual solvent EtOH 0.1 7% by weight, methyl formate, trimethyl orthoformate, toluene, MeOH, and m-xylene were not detected. It will not be served. 1 H NMR(DMSO-d6)δ1.65(d,3H),3.89(s, 3H),4.55(d,2H),5.29(m,1H),7.09(s,2H),7.1 7(dd,1H),7.33(m,1H),7.43(d,2H),7.51(dd,1 H), 7.75(d,2H), 8.86(m,1H).

[0101] Example 1 5-Amino-3-[4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl 1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]phenyl]-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyridine Razol-4-carboxamide [ka] N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro -1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro-2 -Methoxybenzamide (20 g, 43.4 mmol), MsOH (80 mL, 1220 (1.50 g, 83.3 mmol) and water (1.50 g, 83.3 mmol) were added together and the mixture was stirred. The reaction temperature is maintained at 85° C. for 6 hours and then cooled to 20° C. In a separate container, add water (100 mL) and NH4OH in water (28 wt%, 200 mL, 100 Add 100 mmol) and cool to 0-10°C. While maintaining the temperature at 0-10°C, add acid The reaction mixture is poured slowly into the NH4OH solution over 6-7 hours. The reaction mixture is then cooled to 100°C. (20 mL) for 30 min at 5-20°C, while maintaining the temperature at 5-20°C during the addition. Add NH4OH to the quench solution over 1-2 hours. Heat to 25°C, charge EtOAc (140 mL), and stir the mixture at 15-25°C for 30 min. Stir and then leave for 30 min. Remove the aqueous layer. Add Et at 20° C. with stirring for 30 min. Add water (100 mL) to the OAc solution and then let the layers stand for 30 min. Separate the aqueous layer. EtOAc (130 mL) was added to the existing EtOAc solution and stirred at 20 °C for 30 min. The organic layer is then concentrated under vacuum to 140 mL at a temperature below 50° C. Additional Et Charge OAc (120 mL) and stir at 20° C. for 30 min, then at a temperature below 50° C. Concentrate under vacuum until the total volume is 140 mL. Charge EtOH (120 mL) and Concentrate the mixture at a temperature below 50 °C until the total volume of the solution is 120 mL. Add 20 mL of ethyl acetate and concentrate to a total solution volume of 120 mL twice. Adjust the solution temperature to 42°C. Add EtOH (12 mL) and heat to 50-60°C. L) is added over 30 minutes at 50-60°C. 1-[(1S)-2,2-methoxy-benzoyl)amino]methyl]phenyl]- ,2-Trifluoro-1-methyl-ethyl]pyrazole-4-carboxamide seed crystals (0 Add 0.40 g, 0.83 mmol) and stir the mixture at 50-60°C for 3-4 hours. The first portion of n-heptane (56 mL) was added at a constant rate over 5 hours at 50-60°C. The second portion of n-heptane (93 mL) was added at a constant rate over 5 hours at 55 °C. The mixture is cooled to 15°C for 4 hours and stirred for an additional 4 hours. The solids are collected and added to the wet cake. The mixture was dried at 50°C for 66 hours to give the title compound (17.5 g, 84% yield) as a white solid. And get it.

[0102] Example 2 5-Amino-3-[4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl 1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]phenyl]-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyridine Razol-4-carboxamide [ka] 5-Amino-3-[4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl 1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]phenyl]- Pyrazole-4-carboxamide (3.5 kg, 7.30 mol) was dissolved in MeOH (17.5 Add 10 mL of water to the flask and stir the solution and heat it to 50-60°C. Maintain the temperature at 50-60°C for 1 hour. The solution is polish filtered, rinsed with MeOH (3.5 L), and transferred to combine with the substrate solution. Adjust the temperature to 55-65°C and stir for 0.5-1 hour. Maintain the temperature at 55-65°C. Add water (9450 mL) dropwise over 1-2 hours while stirring at 91 RPM. The temperature was then adjusted to 50-60°C, and then 5-amino-3-[4-[[(5-fluoro-2 -Methoxy-benzoyl)amino]methyl]phenyl]-1-[(1S)-2,2,2- Seed crystals of trifluoro-1-methyl-ethyl]pyrazole-4-carboxamide (35 g, Add 73 mmol) and continue stirring at 50-60°C for 1-2 hours. While stirring, add water (4.55 L) dropwise over 8 to 10 hours. Then, mix the mixture for 5 Cool to ~15°C for 5-7 hours and maintain the mixture at 5-15°C for 2-4 hours. Solid The solid is collected and washed with MeOH:water (3:2) solution (2×3.5 L). The title compound (3312 g, 95% yield, 100% purity) was obtained as an off-white is obtained as a solid. 1 H NMR(400MHz,DMSO-d6)δ1.62(d,3 H),3.89(s,3H),4.56(d,2H),5.30(m,1H),6.68 (bs,2H),7.18(dd,1H),7.33(m,1H),7.43(d,2H ),7.47(d,2H),7.52(dd,1H),8.83(m,1H)

[0103] Preparation 5 3,5-Diamino-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl] Pyrazole-4-carbonitrile [ka] [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine hydrochloride(0 .5g, 3mmol) and potassium (dicyanoethenylidene)azanide (0.4g, 3mmol) mol) is combined with water (2 mL) in a pressure flask and heated to 100 °C overnight. Cool to room temperature and a precipitate forms. Filter the precipitate and concentrate the aqueous filtrate in vacuo. The residue was then dissolved in DCM (1 mL) and purified by silica gel chromatography (with gradient elution). The product-containing fractions were combined and purified using 0-100% EtOAc in hexanes. and concentrate in vacuo to give the title compound (130 mg, 593 μmol, 20% yield). ES / MS m / z=220.1(M+H). 1 H NMR 400MHz, (DMSO -d6)δ1.46(d,J=1.00Hz,3H),4.91-5.09(m,1H) ,5.31(s,2H),6.67(s,2H).

[0104] Preparation 6 5-Amino-3-bromo-1-[(1S)-2,2,2-trifluoro-1-methyl- Tyl]pyrazole-4-carbonitrile [ka] 3,5-Diamino-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl ]pyrazole-4-carbonitrile (56.6 mg, 258 μmol) and ACN (2 m To the resulting solution was added copper(II) bromide (57.7 mg, 12.1 μL, 258 μmol), The mixture is stirred for 20 minutes while cooling in a brine / ice bath. Chiral (26.6 mg, 30.8 μL, 258 μmol) was dissolved in ACN (2 mL) and reacted. The reaction mixture is stirred at -20°C for 2 hours. The reaction is then diluted with water (6 mL ), extract the organics with EtOAc (3 × 20 mL), and add sodium sulfate. Dry, filter and concentrate in vacuo. The residue is purified by silica gel chromatography (gradient eluent The product was purified using 0-100% EtOAc in heptane as the eluent. Empty and concentrate to give the title compound (21 mg, 74 μmol, 29% yield). ES / MS m / z( 79 Br / 81 Br)=283.00 / 285.00(M+); 1 H NMR 400MHz, (DMSO-d6)δ1.58(d, J=1.00Hz, 3H), 5. 17~5.30(m,1H), 7.40(s,2H).

[0105] Preparation 7 5-Amino-3-bromo-1-[(1S)-2,2,2-trifluoro-1-methyl- Tyl]pyrazole-4-carboxamide [ka] In a 20 mL reaction vial, 5-amino-3-bromo-1-[(1S)-2,2,2- Trifluoro-1-methyl-ethyl]pyrazole-4-carbonitrile (16.5 mg, 58.3 μmol) and Ghaffar-Parkins catalyst (25.0 mg, 58.3 The mixture is heated to 80° C. After cooling to room temperature, the mixture was passed through a 0.45 μm filter. The residue is purified by silica gel chromatography (gradient elution). Purify using 0-10% MeOH and 0.1% NH4OH in DCM. The containing fractions were combined and concentrated in vacuo to give the title compound (12.5 mg, 41.5 μmol, yield The product was obtained as a white solid (71%). 79 Br / 81 Br)=301 .0 / 303.0(M+); 1 H NMR 400MHz, (DMSO-d6) δ1.5 6(d,J=1.00Hz,3H),5.18-5.39(m,1H),6.54(br s, 1H), 6.98 (s, 2H), 7.31 (brs, 1H).

[0106] Preparation 8 5-Amino-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazo 4-carbonitrile [ka] [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine hydrochloride(0 .5g, 3mmol), DIEA (0.8g, 1mL, 6mmol) and EtOH (25 1 mL) in a round bottom flask. The reaction mixture is stirred for 30 minutes until the hydrazine solid dissolves. The mixture was stirred for 10 minutes. Then, 2-(ethoxymethylene)propanedinitrile (0.4 g, 3 ml) was added. mol) is added portionwise to the reaction mixture and the reaction vessel is sealed. The reaction is stirred at 60 °C overnight. The reaction is concentrated in vacuo and purified by silica chromatography (hexanes as gradient eluent). Purify using 0% to 100% EtOAc in water. Combine the product-containing fractions and concentrate in vacuo. Condensation affords the title compound (385 mg, 1.89 mmol, 60% yield). ES / MS m / z=204.9(M+H); 1 H NMR 400MHz, (DMSO-d6)δ 1.58(d,J=1.00Hz,3H),5.13-5.30(m,1H),7.00 (s,2H),7.66(s,1H).

[0107] Preparation 9 tert-Butyl N-tert-butoxycarbonyl-N-[4-cyano-2-[(1S )-2,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]carbame R [ka] (S)-5-amino-1-(1,1,1-trifluoropropan-2-yl)-1H- Pyrazole-4-carbonitrile (290 mg, 1 equiv., 1.42 mmol) was added to a round-bottom flask. Dissolve in THF (5 mL) in a raspberry jar. Then add DMAP (17.4 mg, 0.1 equiv. , 142 μmol), BOC2O (620 mg, 653 μL, 2 equivalents, 2.84 mmol ), and TEA (431 mg, 594 μL, 3 equiv, 4.26 mmol) were added to the reaction. The reaction mixture is stirred at ambient temperature overnight. The reaction is diluted with saturated aqueous NH4Cl (15 mL ) and extract through a phase separator frit with DCM (3 x 15 mL). The residue was concentrated in vacuo and purified by silica chromatography (0-10% in hexane as gradient eluent). 0% EtOAc). The product-containing fractions were combined and concentrated in vacuo to give the product shown in table The title compound is obtained (409.8 mg, 1.013 mmol, 71% yield). 1 H NMR 400MHz,(DMSO-d6)δ7.82(s,1H),4.58(m,1H),1 .68-1.66(d,3H),1.41(s,9H),1.37(s,9H).

[0108] Preparation 10 tert-Butyl N-tert-butoxycarbonyl-N-[4-cyano-5-(4,4 ,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-[(1S) -2,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]carbamate to [ka] BISPIN (47 mg, 1.5 equivalents, 0.19 mmol), tert-butyl Nt ert-Butoxycarbonyl-N-[4-cyano-2-[(1S)-2,2,2-triphenylphosphine [fluoro-1-methyl-ethyl]pyrazol-3-yl]carbamate (50 mg, 0.1 2mmol), (1,5-cyclooctadiene)(methoxy)iridium(I) dimer ( 1 mg, 2 μmol), and 4-tert-butyl-2- (4-tert-butyl-2- Pyridyl)pyridine (1 mg, 4 μmol) was placed in a microwave vial with 1,4-dioxa Combine with 0.5 mL of ethanol. Seal the reaction vial and heat to 80 °C for 2 h. The material was cooled to ambient temperature, diluted with DCM (20 mL) and then passed through a phase separation frit. Extract with DCM (3 x 20 mL). Concentrate the organics in vacuo. The residue is then evaporated to dryness. using 0-100% EtOAc in heptane as gradient eluent. The product-containing fractions are combined, concentrated in vacuo, and then dried in vacuum. The residue is purified by pentane distillation. The precipitate was suspended in ethanol (4 mL), sonicated for 4 min, and then the precipitate was isolated by filtration to give the title compound. The compound (20 mg, 38 μmol, 30% yield) is obtained. 1 H NMR 400MHz, (DMSO-d6)δ5.71(m,1H),1.60(d,3H),1.39(s,9 H), 1.38(s,9H), 1.32(S,12H).

[0109] Preparation 11 N-[(4-bromophenyl)methyl]-5-fluoro-2-methoxy-benzamide [ka] 5-Fluoro-2-methoxybenzoic acid (10.0 g, 58. 8mmol) and 4-bromobenzylamine (10.9g, 58.8mmol) were mixed with stirring. The mixture contained DIEA (22.8 g, 176.3 mmol) and T3P (44.9 g, 70. 5 mmol, 50% in EtOAc) is added dropwise at room temperature under N2. The resulting mixture is Stir at 50° C. for 1.5 h. Cool the mixture to room temperature. Add room temperature water (150 mL). The reaction is quenched by the addition of EtOAc (2×150 mL). The combined organic layers are washed with brine (2×100 mL) and extracted with anhydrous Na2SO4. After filtration, the filtrate was concentrated under reduced pressure to give the title compound (17 g, 84% yield) as a yellow solid. Obtained as a coloured solid. 1 H NMR 300MHz,(CDCl3)δ8.28(s,1H ),7.94(dd,1H),7.51-7.41(m,2H),7.31-7.20( m,2H),7.18-7.11(m,1H),6.93(dd,1H),4.62(d ,2H),3.92(s,3H).

[0110] Preparation 12 tert-Butyl N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl ]Methyl]carbamate [ka] 4-[(tert-butoxycarbonylamino)methyl]ammonium chloride in DCM (200 mL) Benzoic acid (10.0 g, 39.8 mmol) and malononitrile (3.39 g, 51.3 mmol). To a stirred mixture of 1000g (1.0 mmol), DIEA (25.7 g, 198.98 mmol) was added and cooled under N To the above mixture, T3P (75.97 g, 119.4 mmol, EtOAc Add dropwise 50% of 100% ethanol at room temperature over 30 minutes. Stir the resulting mixture for an additional 2 hours at room temperature. The reaction is quenched with water (200 mL) and extracted with DCM (3 x 200 mL). The organic layer was washed with saturated aqueous NaCl (2×100 mL) and dried over anhydrous Na2SO4. After filtration, the filtrate is concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the title compound (10. 5 g, 88%) as a dark orange oil. 1 H NMR 400MHz, (DMSO-d 6)δ8.17(s,1H),7.52(d,2H),7.21(d,2H),4.14 (d,2H), 1.40(s,9H).

[0111] Preparation 13 tert-Butyl N-[[4-(2,2-dicyano-1-methoxy-vinyl)phenyl] Methyl]carbamate [ka] tert-Butyl N-[[4-(2,2-dicyano-1-phenyl)- hydroxy-vinylphenylmethylcarbamate (10.5g, 35.1mmol) To the stirred solution of TEA (10.7 g, 105.2 mmol) was added in small portions at room temperature under N2. To the above mixture, add dimethyl sulfate (26.6 g, 210.5 mL) in THF (2 mL). The resulting mixture is stirred at 50° C. for a further 3 hours. Cool to room temperature. Quench the reaction with water (200 mL) and EtOAc (2×200 mL). The combined organic layers are washed with brine (3×100 mL) and anhydrous NaSO Dry at 4. After filtration, the filtrate is concentrated under reduced pressure. The residue was purified by silica gel column chromatography eluting with 50 mL of ethyl acetate to give the title compound ( 10.9 g, 99% yield, is obtained as a dark yellow oil.1 H NMR 300MHz, (D MSO-d6)δ7.67-7.59(m,2H),7.46(d,2H),4.24( d, 2H), 3.89 (s, 3H), 1.41 (s, 9H).

[0112] Preparation 14 tert-Butyl N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2 -Trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]carboxamide Bamet [ka] tert-Butyl N-[[4-(2,2-dicyano-1-meth 1.00g, 3.191mmol, 1 To a stirred solution of [(1S)-2,2,2-trifluoro-1-methyl-ethyl [0.53 g, 3.2 mmol]hydrazine hydrochloride and TEA (0.65 g, 6.3 8 mmol) is added at room temperature. The resulting mixture is stirred at 50°C for 2 hours. The mixture is cooled to room temperature. The resulting mixture is concentrated under reduced pressure. PE / EtOAc (5: The residue was purified by silica gel column chromatography eluting with 1:1 to 3:1 The title compound (1.2 g, 92% yield) is obtained as a yellow solid. 1 H NMR 400MHz ,(DMSO-d6)δ7.72(d,2H),7.33(d,2H),7.09(s, 2H),5.32-5.25(m,1H),4.15(d,2H),1.65(d,3H ),1.40(s,9H).

[0113] Preparation 15 5-Amino-3-[4-(aminomethyl)phenyl]-1-[(1S)-2,2,2-trimethylphenyl] Trifluoro-1-methyl-ethyl]pyrazole-4-carbonitrile hydrochloride [ka] Add tert-butyl N-[[4-[5-amino-4-cyano- 1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole-3-yl [phenyl]methyl]carbamate (1.20 g, 2.93 mmol) and HCl (1 4-Dioxane (4M, 7 mL) is added at room temperature. The resulting mixture is stirred at room temperature for 1 hour. The mixture is concentrated in vacuo, then washed with EtO (3×5 mL) and concentrated again in vacuo. The crude product was carried on to the next step without further purification. Used directly. ES / MS m / z=310.1[M+H] + . 1 H NMR 400M Hz,(DMSO-d6)δ8.50(s,2H),7.84-7.71(m,2H), 7.64-7.53(m,2H),7.20(s,2H),5.45-5.38(m,1 H),4.08-4.04(m,2H),1.65(d,3H).

[0114] Preparation 16 5-Amino-3-[4-(aminomethyl)phenyl]-1-[(1S)-2,2,2-trimethylphenyl] Trifluoro-1-methyl-ethyl]pyrazole-4-carboxamide [ka] 5-Amino-3-[4-(aminomethyl) (1S)-2,2,2-trifluoro-1-methyl-ethyl]phenyl 120 mg (0.388 mmol) and NaOH (77 To a stirred mixture of 0.6 mg, 1.94 mmol) was added H2O2 (0.7 ml, 30% in H2O). ) is added dropwise at room temperature. The resulting mixture is then stirred at 50° C. for 2 hours. The mixture is then cooled to room temperature. The mixture was cooled to rt and then concentrated in vacuo. The crude product (100 mg) was purified by Prep-HPLC ( XBridge Prep C18 OBD™ Column, 19 x 150 mm, 5 μm ; Mobile phase A: water (10 mmol / L NH4HCO3), mobile phase B: ACN; flow rate: 25 (mL / min; Gradient: 10% B to 26% B in 6 min, 26% B; Wavelength: 254 / 220 nm) The product-containing fractions were lyophilized to give the title compound (15.2 mg, 12% yield). %) as a white solid. ES / MS m / z=328.2[M+H] + . 1 H.N.M. R 400MHz,(DMSO-d6)δ7.55-7.31(m,4H),5.21( q,1H),4.19(t,0.5H),3.78(t,1.5H),1.75-1.5 0(m,3H).

[0115] Preparation 17 [5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro-1-methyl- Ethyl]pyrazol-3-yl]boronic acid [ka] tert-Butyl N-tert-butoxycarbonyl-N-[4-cyano-5-(4, 4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-[(1S )-2,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]carbame The acetone (25 mg, 47 μmol) was dissolved in DCM (1 mL) and TFA (0.54 g, 0 Treat with 1.36 mL, 4.7 mmol). Stir the reaction at ambient temperature for 3 h. Product The elution was performed by silica chromatography (gradient elution with 0-100% EtOAc in hexanes). c) was used to purify the product directly without workup. The product-containing fractions were combined and concentrated in vacuo. To obtain the title compound (7 mg, 0.03 mmol, 60% yield). 1 H NMR 400 MHz,(DMSO-d6)δ.67(d,J=1.00Hz,3H),5.33-5. 58(m,1H),9.03(brs,2H),11.56(s,1H)12.46(s ,1H).

[0116] Preparation 18 4-(2-Methoxy-2-oxo-ethyl)benzoic acid [ka] To a stirred solution of HCl (gas) in MeOH (1000 mL, 0.3 N), 4-(carbocyanine) Add 100 g (278 mmol) of 1,2-dimethoxymethylbenzoic acid at 0° C. The mixture is stirred at 0° C. for 1 hour. The resulting mixture is concentrated under reduced pressure while maintaining the temperature below 20° C. The residue is recrystallized from PE / EtOAc (120 mL / 40 mL) to give the title compound. The compound (40.0 g, 74% yield) is obtained as an off-white solid. 1 H NMR 4 00MHz,(DMSO-d6)δ12.93(s,1H),7.91(d,2H),7 .40(d,2H),3.79(s,2H),3.63(s,3H).

[0117] Preparation 19 Methyl 2-[4-(2,2-dicyano-1-methoxy-vinyl)phenyl]acetate [ka] 4-(2-Methoxy-2-oxo-ethyl)benzoic acid (40) in DCM (300 mL) A few drops of DMF are added to a stirred solution of 1.0 g, 206.2 mmol) of ethyl acetate. Xalyl (31.4 g, 247.4 mmol) is added dropwise at 0° C. The resulting mixture is heated to room temperature. The mixture was concentrated under reduced pressure to give crude methyl 2-(4-chlorocarbonyl) In another bottle, add malononitrile in THF (100 mL) to obtain phenyl acetate. A solution of (13.61 g, 206.2 mmol) of NaH(1 Dropwise addition of 6.5 g, 412.4 mmol, 60% in oil to a stirred suspension at 0-10°C under N2 The hydride mixture is then stirred at room temperature for 20 min. THF (200 mL) is then added. ) to the reaction mixture. Add dropwise at ~10°C. Stir the reaction at room temperature for 1 hour. Dimethyl sulfate (31.2 g, 24 7.4 mmol) is added to the reaction. The mixture is refluxed at 80° C. overnight under N2. Add water (300 mL) and extract the organics with EtOAc (3 x 300 mL). The combined organic layers were washed with saturated aqueous NaCl, dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (PE / EtOAc:4 / 1-1 / 1) to give the title compound (42.0 g, 88% yield) as a yellow solid. do. 1 H NMR 400MHz,(CDCl3)δ7.51-7.40(m,4H), 3.96(s,3H),3.75(s,3H),3.74(s,2H).

[0118] Preparation 20 Methyl 2-[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro 1-methyl-ethyl]pyrazol-3-yl]phenyl]acetate [ka] Methyl 2-[4-(2,2-dicyano-1-methoxy-vinyl) To a stirred solution of [(1S)-2 ,2,2-trifluoro-1-methyl-ethyl]hydrazine hydrochloride (231.2 mg, 1 0.40 mmol) and TEA (236.9 mg, 2.34 mmol) were added at room temperature under N2. The resulting mixture is stirred at 50 °C under N2 for 2 h. The mixture is cooled to room temperature and reduced pressure is added. Concentrate under reduced pressure. Column chromatography on silica gel eluted with PE / EtOAc (4:1 to 1:1). The residue was purified by chromatography to give the title compound (210 mg, 51% yield) as a white solid. ES / MS m / z=353.1[M+H] + .

[0119] Preparation 21 2-[4-[5-amino-4-carbamoyl-1-[(1S)-2,2,2-trifluoro 1-methyl-ethyl]pyrazol-3-yl]phenyl]acetic acid [ka] Methyl 2-[4-[5-amino- 4-Cyano-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazo A stirred solution of 1,3-diphenyl-3-ylphenylacetate (100 mg, 0.284 mmol) Into the solution, NaOH (34.1 mg, 0.85 mmol) and H2O2 (0.5 mL in H2O) were added. 30%) is added at room temperature under N2. The resulting mixture is stirred at 50 °C under N2 for 2 h. The mixture is cooled to room temperature and then acidified to pH 5 with aqueous HCl (1N). The mixture is extracted with EtOAc (3×10 mL). The combined organic layers are washed with saturated aqueous NaCl. (2×10 mL) and dried over anhydrous Na2SO4. After filtration, the filtrate was concentrated under reduced pressure. The crude product is purified by Prep-HPLC under the following conditions (column: XSe lect CSH Prep C18 OBD™ column, 19 x 150 mm, 5μ m; Mobile phase A: water (0.05% FA), Mobile phase B: ACN; Flow rate: 25 mL / min; Gradient: 15%B to 44%B in 8 min; wavelength: 254 / 220 nm. Product-containing fractions were Lyophilize to obtain the title compound (18.4 mg, 18% yield) as a white solid. MS m / z=357.05[M+H] + . 1 H NMR 400MHz, (DMSO- d6)δ7.43(d,2H),7.35(d,2H),6.66(brs,3H),5 .34-5.23(m,2H),3.62(s,2H),1.61(d,3H).

[0120] Preparation 22 2-[4-[5-amino-4-cyano-1-(2,2,2-trifluoro-1-methyl- Ethyl)pyrazol-3-yl]phenyl]acetic acid [ka] Methyl 2-[4-[5-amino-4-cyano] No-1-(2,2,2-trifluoro-1-methyl-ethyl)pyrazol-3-yl] phenyl]acetate (3.20 g, 9.08 mmol) and LiOH (0.65 g, 27 A solution of 1.3 mmol) was stirred at room temperature for 2 h. The reaction was concentrated under reduced pressure to remove the solvent. Then EtOAc (10 mL) is added. The filter cake is dissolved in water (50 mL) and Acidify with aqueous HCl (4 M) to pH 6. The resulting mixture is diluted with EtOAc (3×10 The combined organic layers were washed with saturated aqueous NaCl (2×50 mL) and Dry over anhydrous Na2SO4. After filtration, the filtrate was concentrated under reduced pressure to give crude compound (3 g, 9 7%) as a brown solid. ES / MS m / z=339.2[M+H] + .

[0121] Preparation 23 Benzyl N-[[4-[5-amino-4-cyano-1-(2,2,2-trifluoro-1 -Methyl-ethyl)pyrazol-3-yl]phenyl]methyl]carbamate [ka] 2-[4-[5-amino-4-cyano-1-(2,2 ,2-Trifluoro-1-methyl-ethyl)pyrazol-3-yl]phenyl]acetic acid (1 .00g, 2.956mmol, 1.00eq) and benzyl alcohol (383.60 To a stirred solution of TEA (598.2 mg, 5 .91 mmol) and DPPA (1.22 g, 4.43 mmol) were added dropwise at room temperature under N2. The resulting mixture is stirred at 110 °C under N2 overnight. The mixture is cooled to room temperature. Concentrate under reduced pressure. Columns are eluted with PE / EtOAc (2:1 to 1:1). The title compound (300 mg, 23% yield) was obtained by purification using gel column chromatography. ) as a yellow solid. ES / MS m / z=444.1[M+H] + . 1 H NMR 400MHz,(DMSO-d6)δ7.90-7.86(m,1H),7.79-7 .69(m,2H),7.38-7.32(m,6H),7.10(s,2H),5.3 5-5.06(m,1H),5.06(s,2H),4.31-4.24(m,2H), 1.66(d,3H).

Claims

1. (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl (phenyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazo A process for the preparation of aryl-4-carboxamide (I), comprising the steps of: viii) a compound of formula (III) [Case 1] , (In the formula, PG 1 is -CH 3 , -CH 2 CH 3 , -C(CH 3 ) 3 , -CH 2 CH=CH 2 , methoxymethyl, tetrahydropyran, benzyl, trimethylsilyl, tert-butyl di-tert-butyldimethylsilyl, di-tert-butylisobutylsilyl, di-tert-butyl[ pyren-1-ylmethoxy]silyl, tert-butyldiphenylsilyl, acetyl, or is benzoyl), and [(1S)-2,2,2-trifluoro-1-methyl-ethyl ]hydrazine (8) or a salt thereof to give N-[[4-[5-amino-4 -Cyano-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyrazole [0021] 10-fluoro-3-yl]phenyl]methyl]-5-fluoro-2-methoxy-benzamide (10 ) or a salt thereof; ix) N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-triphenylphosphine [Fluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro 2-Methoxy-benzamide (10) or its salt to produce (S)-5-amino-3-(4-methoxy-benzamide -((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1, 1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide (I) and x) optionally, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzyl) amido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)- 1H-pyrazole-4-carboxamide (I) was crystallized to give the crystalline form of (S)-5-aryl. 3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)- 1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carbo providing an oxamide (I); The method includes:

2. The compound of formula (III) [Case 2] , [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine (8) or Prior to the coupling step with the salt of N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl]-5 2-fluoro-2-methoxy-benzamide (II) is reacted with an alkylating agent to obtain a compound of the formula The method of claim 1 further comprising obtaining the compound of formula (III). [C3]

3. The compound of formula (III) and [(1S)-2,2,2-trifluoro-1-methyl- prior to the coupling step with ethyl]hydrazine (8), [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine hydrochloride (7 ) to [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine (8). The method of claim 1 or 2, further comprising a converting step.

4. [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine hydrochloride (7 ) to [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine (8). Before conversion, N'-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]benzohydrazine and reacting (6) or a salt thereof with [(1S)-2,2,2-trifluoro-1-methyl 4. The method of claim 3, further comprising obtaining [-ethyl]hydrazine hydrochloride (7).

5. N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl]-5 Before reacting 2-fluoro-2-methoxy-benzamide (II) with an alkylating agent, 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzoyl The chloride (4) is reacted with malononitrile to give N-[[4-(2,2-dicyano-1-hydroxy- hydroxy-vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzamide ( The method of any one of claims 2 to 4, further comprising the step of obtaining II).

6. 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzoyl Prior to reacting the halide (4) with malononitrile, 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzoic acid (3 ) or a salt thereof, ] to benzoyl chloride (4).

7. 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzoic acid (3 ) or a salt thereof, 5-Fluoro-2-methoxy-benzoyl chloride (2) with 4-(aminomethyl)benzoyl chloride Coupling with aromatic acid to give 4-[[(5-fluoro-2-methoxy-benzoyl)amine The method of claim 6, further comprising the step of obtaining benzoic acid (3) or a salt thereof. Law.

8. 5-Fluoro-2-methoxy-benzoyl chloride (2) with 4-(aminomethyl)benzoyl chloride Before coupling with aromatic acid, 5-Fluoro-2-methoxy-benzoic acid (1) or a salt thereof is converted to 5-fluoro- The method of claim 7, further comprising the step of obtaining 2-methoxy-benzoyl chloride (2). method.

9. (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl (phenyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazo A process for the preparation of aryl-4-carboxamide (I), comprising the steps of: i) 5-fluoro-2-methoxy-benzoic acid (1) or a salt thereof is reacted with 5-fluoro-2-methoxy-benzoic acid (2) or a salt thereof is reacted with 5-fluoro-2-methoxy-benzoic acid (3) or a salt thereof is reacted with 5-fluoro-2-methoxy-benzoic acid (4) or a salt thereof is reacted with 5-fluoro-2-methoxy-benzoic acid (5) or a salt thereof is reacted with 5-fluoro-2-methoxy-benzo converting the benzoyl chloride (2) to benzoyl chloride (3); ii) 5-fluoro-2-methoxy-benzoyl chloride (2) with 4-(aminomethyl ) benzoic acid to give 4-[[(5-fluoro-2-methoxy-benzoyl ) obtaining amino]methyl]benzoic acid (3) or a salt thereof; iii) 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzo Fragrance acid (3) or its salt is reacted with 4-[[(5-fluoro-2-methoxy-benzoyl)amino] methyl]benzoyl chloride (4); iv) 4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzo The aryl chloride (4) is reacted with malononitrile to give N-[[4-(2,2-dicyano- 1-Hydroxy-vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzaldehyde obtaining mido (II); v) N'-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]benzohydrin The azide (6) or a salt thereof is reacted with [(1S)-2,2,2-trifluoro-1-methyl-ethyl hydrazine hydrochloride (7); vi) [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine hydrochloride The salt (7) was reacted with [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine ( 8) converting vii) N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl [0036] 5-fluoro-2-methoxy-benzamide (II) is reacted with a compound of formula (III) [C4] , (In the formula, PG 1 is -CH 3 , -CH 2 CH 3 , -C(CH 3 ) 3 , -CH 2 CH=CH 2 , methoxymethyl, tetrahydropyran, benzyl, trimethylsilyl, tert-butyl di-tert-butyldimethylsilyl, di-tert-butylisobutylsilyl, di-tert-butyl[ pyren-1-ylmethoxy]silyl, tert-butyldiphenylsilyl, acetyl, or is benzoyl; viii) a compound of formula (III) [C5] , [(1S)-2,2,2-trifluoro-1-methyl-ethyl]hydrazine (8) or N-[[4-[5-amino-4-cyano-1-[(1S) -2,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl] methyl]-5-fluoro-2-methoxy-benzamide (10) or a salt thereof. P and ix) N-[[4-[5-amino-4-cyano-1-[(1S)-2,2,2-triphenylphosphine [Fluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]-5-fluoro 2-Methoxy-benzamide (10) or its salt to produce (S)-5-amino-3-(4-methoxy-benzamide -((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1, 1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide (I) and x) optionally (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzaldehyde (1,1,1-trifluoropropan-2-yl)-1-(1,1,1-trifluoropropan-2-yl)- H-pyrazole-4-carboxamide (I) was crystallized to give (S)-5-amino- No-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1 -(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxylate Providing an amide (I); The method includes:

10. (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl (phenyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazo A method for preparing N-[[4-(2,2-dicyanoyl-4-carboxamide (I)] -1-Methoxy-vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benzaldehyde S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamide) 1-(1,1,1-trifluoropropan-2-yl)-1H-phenyl and converting the compound into isopropyl alcohol (I).

11. (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl (phenyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazo A method for preparing N-[[4-(2,2-dicyanoyl-4-carboxamide (I)] -1-hydroxy-vinyl)phenyl]methyl]-5-fluoro-2-methoxy-benz The amide was reacted with S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamide ) methyl) phenyl) -1- (1,1,1-trifluoropropan-2-yl) -1H- converting the compound to pyrazole-4-carboxamide (I).

12. N-[[4-(2,2-dicyano-1-hydroxy-vinyl)phenyl]methyl]-5 The compound is -fluoro-2-methoxy-benzamide. [C6]

13. (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl (phenyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazo 13. Use of the compound according to claim 12 in the preparation of aryl-4-carboxamide (I).

14. compound [C7] , (In the formula, PG 1 is -CH 3 , -CH 2 CH 3 , -C(CH 3 ) 3 , -CH 2 CH=CH 2 , methoxymethyl, tetrahydropyran, benzyl, trimethylsilyl, tert-butyl di-tert-butyldimethylsilyl, di-tert-butylisobutylsilyl, di-tert-butyl[ pyren-1-ylmethoxy]silyl, tert-butyldiphenylsilyl, acetyl, or is benzoyl).

15. P.G. 1 Ga-CH 3 15. The compound of claim 14, wherein

16. 15. The compound of claim 14, wherein: [C8]

17. (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl (phenyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazo 15. Use of the compound according to claim 14 for the preparation of aryl-4-carboxamide (I).

18. The compound of formula (III) according to any one of claims 1 to 3, wherein the compound of formula (III) is a compound of formula (IIIA):

3. The method according to claim 1 . [C9]

19. A compound selected from the group consisting of [C10] (In the formula, PG 2 is fluorenylmethoxycarbonyl, tert-butoxycarbonyl, Benzylcarbonyl, trifluoroacetamide, phthalimide, benzyl, triphenyl dimethyl, benzylideneamine, p-toluenesulfonamide, PG 1 is -CH 3 , -CH 2 CH 3 , -C(CH 3 ) 3 , -CH 2 CH=CH 2 , methoxymethyl, tetramethyl Hydropyranyl, benzyl, trimethylsilyl, tert-butyldimethylsilyl, di -tert-butylisobutylsilyl, di-tert-butyl[pyren-1-ylmethoxy] silyl, tert-butyldiphenylsilyl, acetyl, or benzoyl).

20. 3,5-Diamino-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl ]pyrazole-4-carbonitrile: [C11] , or a salt thereof.

21. 5-Amino-3-bromo-1-[(1S)-2,2,2-trifluoro-1-methyl- Ethyl]pyrazole-4-carbonitrile: [C12] , or a salt thereof.

22. 5-Amino-3-bromo-1-[(1S)-2,2,2-trifluoro-1-methyl- Ethyl]pyrazole-4-carboxamide: [C13] , or a salt thereof.

23. 5-Amino-1-[(1S)-2,2,2-trifluoro-1-methyl-ethyl]pyra ZOLE-4-CARBONITRILE: [C14] , or a salt thereof.

24. tert-Butyl N-tert-butoxycarbonyl-N-[4-cyano-2-[(1 S) -2,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]carba 20. The compound of claim 19 which is a mate. [C15]

25. tert-Butyl N-tert-butoxycarbonyl-N-[4-cyano-5-(4, 4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-[(1S )-2,2,2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]carbame 20. The compound of claim 19, which is a carboxylate. [C16]

26. tert-Butyl N-[[4-[5-amino-4-cyano-1-[(1S)-2,2, 2-trifluoro-1-methyl-ethyl]pyrazol-3-yl]phenyl]methyl]ca Lubamate: [C17] , or a salt thereof.

27. 5-Amino-3-[4-(aminomethyl)phenyl]-1-[(1S)-2,2,2- trifluoro-1-methyl-ethyl]pyrazole-4-carbonitrile hydrochloride.

20. The compound according to claim 19. [C18]

28. 5-Amino-3-[4-(aminomethyl)phenyl]-1-[(1S)-2,2,2- Trifluoro-1-methyl-ethyl]pyrazole-4-carboxamide: [C19] , or a salt thereof.

29. [5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro-1-methyl -Ethyl]pyrazol-3-yl]boronic acid: [C20] , or a salt thereof.

30. Methyl 2-[4-[5-amino-4-cyano-1-[(1S)-2,2,2-trifluoro [0113] [0114] [0115] [0116] [0117] [0118] [0119] [0120] [0121] [0122] [0123] [0124] [0125] [0126] [0127] [0128] [0129] [0130] [C21] , or a salt thereof.

31. 2-[4-[5-amino-4-carbamoyl-1-[(1S)-2,2,2-trifluoro [0113]O-1-methyl-ethyl]pyrazol-3-yl]phenyl]acetic acid: [C22] , or a salt thereof.

32. 2-[4-[5-amino-4-cyano-1-(2,2,2-trifluoro-1-methyl [0046] (-ethyl)pyrazol-3-yl)phenyl]acetic acid: [C23] , or a salt thereof.

33. Benzyl N-[[4-[5-amino-4-cyano-1-(2,2,2-trifluoro- 1-Methyl-ethyl)pyrazol-3-yl]phenyl]methyl]carbamate: [C24] , or a salt thereof.

34. (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl (phenyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazo The process according to any one of claims 19 to 33 for the preparation of aryl-4-carboxamide (I). or any one of claims 20 to 23, claim 26, or claim 28.

34. Use of the salt thereof according to any one of claims 1 to 33.

Citation Information

Patent Citations

  • Compounds useful as kinase inhibitors

    JP2018538307A

  • 5-Aminopyrazolecarboxamide derivatives as BTK inhibitors, and their preparation methods and pharmaceutical compositions

    JP2019519521A

  • Spray-dried dispersions and formulations of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoro propan-2-YL)-1h-pyrazole-4-carboxamide

    WO2020028258A1